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 Zhiwei Pan, PhD 
University of Pittsburgh, 2007
 
 Microbial cultures usually produce a significant amount of acidic byproducts which can 
repress cell growth and product synthesis. In addition, the production of acids is a waste of 
carbon source thereby reducing the product yield and productivity.  
Metabolic engineering provides a powerful approach to optimize the cellular activities 
and improve product yields by genetically manipulating specific metabolic pathways. Previous 
work has identified mutation of pyruvate kinase (PYK) as an efficient way to reduce acid 
production; however, complete abolishment of PYK in Bacillus subtilis resulted in dramatically 
reduced cell growth rate. In this study, an inducible PYK (iPYK) mutant of B. subtilis was 
constructed and extensively characterized. The results demonstrate that good cell growth rate and 
low acetate formation can be attained at an appropriate PYK expression level. In addition, 
mutation of phosphofructokinase (PFK) in the glycolysis pathway also provides an alternative 
approach to reduce acetate formation. 
Two outcomes of the pyk mutant of B. subtilis, high phosphoenolpyruvate (PEP) pool and 
low acetate concentration, prompted us to investigate the employment of the pyk mutation as an 
efficient way to improve folic acid and recombinant protein production. The high intracellular 
PEP and glucose-6-phosphate (G6P) concentrations in the pyk mutant led to higher folic acid 
production by providing abundant synthetic precursors. Additional mutations in the folic acid 
synthesis pathway, along with the pyk mutation, resulted in an 8-fold increase in folic acid 
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production. Recombinant protein was improved two-fold by the pyk mutation due to low acetate 
formation and longer production time in the pyk mutant. In addition, using glycerol instead of 
glucose as the carbon source reduced acetate production and improved protein production by 
60%. 
The effect of citrate on acetate production in Bacillus thuringiensis (Bt) cultures was 
investigated and the continuous culture results show that citrate is very effective at reducing 
acetate formation. These results indicate that pyk may be a potential mutation target for reducing 
acetate formation in Bt.  
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1.0  INTRODUCTION 
Microbes have been used for the production of a variety of products including proteins 
and chemicals that are impossible or difficult to make by chemical synthesis because of the 
complexity of their structure. The rising energy costs and the favorable consideration of 
sustainable development have paved the way for the biological manufacturing route which 
employs an environmentally benign process and utilizes renewable raw materials. However, 
biosynthetic processes are often economically uncompetitive due to their low product 
concentrations in the living organisms. To make biosynthetic processes more competitive, the 
production levels of target products in microorganisms need to be significantly improved. 
Traditional strain improvement efforts have focused on random mutagenesis and screening 
(Beppu, 2000). Recent advances in gene sequencing and genetic engineering have allowed us to 
modify specific biochemical reactions in microorganisms to dramatically improve product 
yields. One of the most powerful technologies for strain improvement is metabolic engineering 
(Bailey, 1991). 
Metabolic engineering is directed improvement of product formation or cellular 
properties through the modification of specific biochemical reactions or introduction of new ones 
to host strains using recombinant DNA technology (Stephanopoulos, 1999). The metabolic 
engineering process typically involves identifying the target reaction(s) based on careful analysis 
of cellular function, designing and genetically modifying the corresponding gene(s) using 
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established molecular biological techniques, followed by comprehensive evaluation and analysis 
of the genetically modified strains (Nielsen, 2001). Typically, additional genetic engineering 
steps are necessary to attain expected goal. 
 With the advances in molecular biological techniques and metabolic pathway analysis as 
well as the availability of genome sequences of most common microorganisms such as Bacillus 
subtilis (Kunst et al., 1997) and E. coli (Blattner et al., 1997; Hayashi et al., 2001) and more 
recently Bacillus thuringiensis ( Han et al., 2004), metabolic engineering has gained increasing 
applications. Nielsen (2001) recently classified the applications of metabolic engineering into 
seven groups: (1) To produce heterogonous proteins, such as producing pharmaceutical proteins 
and novel enzymes from other sources in the production host; (2) To extend substrate range for 
the applied microorganism in order to have a more efficient utilization of the raw materials in 
industrial processes; (3) To introduce pathways leading to new product in the host strain; (4) To 
either introduce pathways from other organisms or engineer existing pathways for degradation of 
environmental pollutant; (5) To engineer cellular physiology for process improvement, such as 
making the cells tolerant to high glucose concentrations or low oxygen concentrations; (6) To 
eliminate or reduce by-product formation; (7) To improve the yield or productivity of target 
product. A few recent successful stories include engineering yeast for improved ethanol 
tolerance and production (Alper et al., 2006), engineering a mevalonate pathway in Escherichia 
coli for the production of terpenoids (Pitera et al., 2006; Martin et al., 2003), and metabolic 
engineering E. coli for the microbial production of 1, 3-propanidiol (Nakamura and Whited, 
2003) which has been commercialized by DuPont in 2006. 
 This thesis will be focused on applying metabolic engineering to reduce acidic by-
products formation and improve biomass yield, enhance heterogonous protein (GFP+ as a model 
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product in this study) production in B. sutbilis, and improve the yield and productivity of native 
metabolites (folic acid as a model product in this study) synthesized by microorganisms. 
Building upon the achievements we have made with B. subtilis, this thesis will also explore the 
feasibility of applying our successful approaches to reduce acetate formation in an agricultural 
important bacterium: Bacillus thuringiensis (Bt). 
1.1 REDUCE ACETATE FORMATION IN MICROBIAL FERMENTATION 
1.1.1 Central Carbon Metabolism and Acetate Formation 
Cell metabolism represents a complex network of several thousand reactions taking place 
at any instance of time. The central carbon metabolism pathway, which consists of glycolysis 
pathway, hexose monophosphate pathway (HMP) and tricarboxylic acid (TCA) cycle, is the 
most important pathway in a living organism as it provides key precursors and energy for the 
synthesis of cell mass components and target products (Figure 1.1) (Gottschalk, 1985). 
Glycolysis or Embden-Meyerhof-Parnas (EMP) pathway is the sequence of ten-step catabolic 
reactions that convert glucose into pyruvate with the concomitant production of a relatively small 
amount of adenosine triphosphate (ATP), the energy currency of the cell. The overall reaction in 
glycolysis pathway can be summarized as the following equation:  
++ +++→+++ HNADHATPpyruvatePiNADADPeglu 2222222cos  
where NAD represents nicotinamide adenine dinucleotide and ADP represents adenosine 
diphosphate. TCA cycle, also known as citric acid cycle or Krebs cycle, starts with the condense 
reaction of four carbon compound oxaloacetic acid and two carbon acetyl CoA to form citrate 
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and contains the final oxidation reactions, coupled to the electron transport chain, which 
produces the majority of the ATP . The overall reaction of TCA cycle is: 
222 233023 COGTPFADHHNADHCoAHPiGDPFADNADCoAAcetyl +++++→+++++− ++
 
where FAD represents flavin adenine dinucleotide and GDP represents guanosine diphosphate. 
The HMP pathway or pentose-phosphate pathway begins with glucose-6-phosphate 
dehydrogenase (G6PDH) which generates NADPH (Nicotine Adenine Dinucleotide Phosphate, 
reduced form), and it is very important for the aromatic amino acid synthesis. 
 Bacteria may be grown under feast or famine condition. When there is an excess supply 
of nutrients such as glucose, bacteria tend to produce a significant amount of by-products. One of 
the key by-products is acetate.  Acetate  accumulates in the medium of most bacterial cultures 
when glucose is employed as the main carbon source and available in high concentrations. The 
acetate production in E. coli and B. subtilis is generally regarded as a result of mismatch between 
excessive glycolytic flux and limited tricarboxylic acid (TCA) cycle capacities (Majewski and 
Domach, 1990). An overflow of glycolystic flux will steer the carbon flow to the production of 
acidic by-products. The overflow of glycolysis could be caused by a limited  TCA cycle flux 
(Han et al., 1992) or a limited capacity of the electron transport chain reactions through the 
cytochrome chain (Ingledew and Poole, 1984; Andersen and Meyenburg, 1980). While the high 
cell growth rate is desirable for high productivity, the overflow of glycolytic flux and formation 
of acetate are more serious problems at high growth rate as some enzymes of the TCA cycle are 
repressed at high growth rates, which further lowers the TCA flux (Fisher and Magasanik, 1984; 
Hanson and Cox, 1967; Grey et al., 1966; Oh and Liao, 2000). Doelle et al. (1982) observed that 
an increase in specific growth rate and an increase in glucose feed concentration in continuous 
culture experiments caused a repression of NADH oxidase activity, which resulted in the 
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accumulation of NADH. Accumulated NADH can repress the enzymes of TCA cycle and thus 
turn excess glycolytic flux to acid by-products. Vemuri et al. (2006) also reported that several 
genes involved in the tricarboxylic acid (TCA) cycle and respiration were repressed as the 
glucose consumption rate increased, and over-expression of NADH oxidase resulted in reduced 
NADH/NAD ratio and eliminated acetate formation (Vemuri et al., 2007). 
 5 
 Figure 1.1. Central carbon metabolism of B. subtilis. 
Abbreviations: aa (amino acids); na (nucleic acids); G6P (glucose-6-phosphate); F6P (fructose-6-phosphate); FDP 
(Fructose-1,3-bisphosphate); DHAP (Dihydroxyacetone-phosphate); R5P (ribose-5-phosphate); E4P (erythrose-4-
phosphate); S7P (sedoheptulose-7-phosphate); GAP (Glyceraldehyde-3-phosphate); PGP (1,3-bisphosphoglycerate); 
3GP (3-phosphoglycerate); P2G (2-phosphoglycerate); PEP (phosphoenolpyruvate); AcCoA (acetyl-CoA); Cit 
(Citrate); KG (α-ketoglutarate); Succ (succinate); OAA (oxaloacetate). 
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1.1.2 Overall Deleterious Effects of Acetate and Its Toxicity Mechanism 
 The acetate is regarded as a toxic by-product of glucose metabolism and its accumulation 
in the culture medium can repress cell growth and inhibit product synthesis in many bacterial 
cultures (Gerigk et al., 2002; van de Walle and Shiloach, 1998; Cierheller et al., 1995; Goel et 
al., 1993). Furthermore, acetate formation results in a loss of carbon, affecting the overall yield 
of biomass and/or a desired product on raw materials (Fieschko and Ritch, 1986). For example, 
in early days, it was thought impossible to grow E. coli to cell densities above 20 g/L as we now 
know it is because of the buildup of toxic metabolic by-products (primarily acetate) that inhibit 
cell growth (Shuler and Kargi, 1992). Nowadays, high-density E. coli cultures of 100 g/L can be 
attained with rational strain design and strict process control. Therefore, reducing acetate 
accumulation during microbial fermentation has become a vital issue for obtaining high cell 
density and productivity.  
 A common explanation of the toxicity of acetate lies in the uncoupling of the proton 
motive force (specifically pH) resulted from the accumulation of acetate in the culture medium. 
Acetate exists in both the ionized (CH3COO-) and protonated (CH3COOH) states at neutral pH. 
The lipophilic protonated form can pass through the lipid membrane to the interior of the cell 
where dissociates to CH3COO- and H+, thereby decreases the intracellular pH (Luli and Strohl, 
1990). Recently, some researchers showed that high glucose concentration which corresponds to 
acetate-forming conditions also activated the methyl glycoxalate pathway in bacteria such as E. 
coli (Weber et al., 2005). The methyl glyoxalate pathway, which converts dihydroxyacetone 
phosphate (DHAP) to pyruvate via methylglyoxal and D-lactate, may short-cut the glycolysis 
pathway and lead to limited energy (ATP) supply for biosynthesis. In addition, methyl glyoxalate 
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itself is a highly toxic compound and may adversely react with deoxyribonucleic acid (DNA), 
ribonucleic acid (RNA) and proteins (Lo et al., 1994; Papoulis et al., 1995). 
 
1.1.3 A Review of Previous Efforts to Reduce Acetate Production 
Since acetate accumulation is highly detrimental to microbial fermentation process, a 
variety of strategies have been investigated in an attempt to reduce problematic acetate formation 
in the past decades. The approaches can be divided into two general categories:  (1) controlling 
process conditions or (2) genetic manipulations of the host strain. Process control solutions 
include removing the toxic byproduct as it accumulates (Landwall and Holme, 1977) and 
keeping the cell growth rate below a critical value where acetate production commences 
(Johnston et al., 2003; Luli and Strohl, 1990). For example, a fed-batch process with controlled 
feeding of glucose successfully reduced the acetate formation (Yoon et al., 1994; Paalme et al., 
1990). However, these techniques can be challenging to implement in practice because of the 
limited availability of direct process measurements. In addition, controlling the growth rate 
below threshold is limited to low growth rates, which increases the process cycle time and 
thereby limits process throughput. 
The genetic manipulation approach involves the application of metabolic engineering to 
reduce carbon flow to the acetate-producing pathways. One strategy is to abolish the activities of 
acetate kinase (ack) and acetyl phosphotransferase (pta), the enzymes catalyze the synthesis of 
acetate (Diaz-Ricci et al., 1991).  
SHCoAPAcetylPCoAAcetyl ptai −+−⎯→⎯+−  
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ATPAcetateADPPAcetyl ack +⎯→⎯+−  
This approach reduced acetate formation in the mutant compared to the parent strain, but resulted 
in significant accumulation of other undesirable by-products such as pyruvate and lactate (Diaz-
Ricci et al., 1991; Yang et al., 1999). 
  
Another strategy is to divert excess glucose to products that are less toxic than acetate, for 
example, engineering E. coli to overproduce glycogen (Dedhia et al., 1994).  
  PyruvatePhosphateeGluPEPeGlu +−−⎯⎯⎯⎯⎯ →⎯+ 6coscos nsferasephosphotra
 
  
PhosphateeGluPhosphateeGlu comutasePhosphoglu −−⎯⎯⎯⎯⎯ →⎯−− 1cos6cos
PieGluUDPOHUTPPhosphateeGlu 2cos1cos asephosphorylUDPG  2 +−⎯⎯⎯⎯⎯ →⎯++−−
  nn glucosyl)-D-α-(1,4glucosyl)-D-α-(1,4 cos +⎯⎯⎯⎯⎯ →⎯+− UDPeGluUDP nthetaseGLucogenSy
where PEP is phosphoenolpyruvate, and UTP is Uridine triphosphate. While glycogen levels 
increased several fold, the acetate production remained unchanged.  
  
In a third approach, the ptsG gene encoding an enzyme in the glucose transferase system was 
mutated. 
  PyruvatePhosphateeGluPEPeGlu pts +−−⎯→⎯+ 6coscos
The mutation resulted in reduced acetate yield, as well as lower growth rate (Chou et al., 1994; 
Chen et al., 1997). Another strategy to manipulate glucose transport is to over-express galactose 
permease to provide an alternate slower route for glucose uptake which resulted in lower glucose 
uptake rate and reduced acetate accumulation and improved recombinant protein production (De 
Anda et al., 2006). 
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Finally, increasd metabolic flux of two anaplerotic pathways through phosphoenolpyruvate 
carboxylase reaction and glyoxylate bypass was examined in E. coli.    
 
PiOAACOOHPEP ppc +⎯→⎯++ 22  
GlyoxylateSuccinateIsocitrate LysateIsocitrate +⎯⎯⎯⎯ →←  
CoAmalateSGlyoxylateOHCoAAcetyl haseMalateSynt +−⎯⎯⎯⎯ →⎯++− 2  
 
where OAA is oxaloacetate, and ppc represents phosphoenolpyruvate carboxylase. This 
approach reduced acetate production by four fold (Farmer and Liao, 1997); however, there was 
no increase in cell density indicating the possibility of glucose conversion to other metabolic by-
products. In addition, this mutation is specific to E. coli since not all microorganisms (for 
example, B. subtilis) possess the enzyme ppc. 
 
1.1.4 A Review of the Approaches in Our Group 
 An alternative approach was found in investigating the possible effect of some TCA 
cycle metabolites on the central carbon metabolism (Goel et al., 1995). It was observed that the 
glycolytic flux remarkably decreased and the acetate formation was eliminated when a small 
amount of citrate was fed into glucose minimal medium in B. subtilis continuous cultures. The 
effectiveness of citrate is rather due to glycolytic inhibition than just serving as a supplement of 
TCA cycle metabolites since adding other metabolites such as glutamine does not have similar 
effect as citrate. It was proposed that the effect of citrate is to attenuate the activities of pyruvate 
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kinase (PYK) and phosphofructose kinase (PFK), which are known to exert significant control 
over glycolysis (Goel et al., 1996). This hypothesis was both supported by experimental 
measurements and metabolic modeling analysis. Metabolic fluxes, pools, and enzyme 
measurements (Goel et al., 1999), as well as NMR experiments results (Phalakornkule et al., 
2000), indicated PYK as a site of citrate-mediated glycolytic flux attenuation. Flux alternatives 
generated from linear programming analysis indicate that the fluxes through glycolysis, the TCA 
cycle, and hexose monophosphate pathway that maximize carbon use also correspond to 
minimized PYK flux (Lee et al., 1997).  
A major shortcoming of this approach was that simultaneous utilization of glucose and 
citrate was only attainable in steady state continuous cultures where residual glucose 
concentration is low. The strategy was not applicable to batch cultures due to high initial glucose 
concentrations limiting citrate transport in batch cultures. The low transport of citrate in high 
glucose cultures is consistent with catabolite repression regulation of citrate transport in B. 
subtilis (Warner et al., 2000; Willecke and Pardee, 1971; Yamamoto et al., 2000). Since 
biotechnological processes aimed at production of proteins, metabolites, or other products are 
almost entirely based on batch or fed-batch cultures, design of a robust strain that will produce 
low levels of acidic byproduct in batch cultures is extremely desirable. It is likely that a PYK 
mutant of B. subtilis may display reduced acid formation without relying on citrate transport and 
such a strategy should also work for batch cultures with high glucose concentration in the feed.   
To directly test the effect of attenuating the PYK-catalyzed flux, both E. coli (Zhu et al., 
2001) and B. subtilis (Fry et al., 2000) bearing interrupted pyk were characterized. The results 
showed substantial reduction in acid formation for both mutants, where both the total amount of 
acetate and the fraction of glucose converted to acetate were reduced. The B. subtilis pyk mutant 
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grew significantly slower than the wild-type and displayed substantially higher intracellular 
concentrations of PEP and glucose-6-phospahte (Fry et al., 2000) than the wild type. The growth 
rate of E. coli pyk mutant was comparable to the wild-type (Zhu et al., 2001). Unlike B. subtilis, 
intracellular concentrations of PEP and glucose-6-phospahte of the wild type and pyk mutant of 
E. coli were similar. The difference between the anaplerotic pathways used by B. subtilis and E. 
coli to produce oxaloacetate (OAA) may explain the substantially elevated PEP pool in B. 
subtilis pyk mutant. Phosphoenolpyruvate carboxylase (PPC) converts phosphoenolpyruvate 
(PEP) to OAA in E. coli, whereas in B. subtilis, OAA is formed via the pyruvate carboxylase–
catalyzed conversion of pyruvate (Figure 1.2). Thus, PEP in B. subtilis pyk mutant accumulates 
but not in E. coli pyk mutant.     
We hypothesized that a pyruvate kinase knockout of B. subtilis mutant may be 
experiencing glucose transport limitation and/or global regulatory changes in response to an 
excess of PEP/G-6-P. It was felt that control of pyk expression at a small value may still maintain 
low acid production and prevent accumulation of PEP and glucose-6-P to levels that will not 
substantially reduce cell’s growth rate.  
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Figure 1.2. Reaction network of B. subtilis and E. coli central carbon metabolism. 
PTS (PEP:sugar phosphotransferase systems) operates in both E. coli and B. subtilis. PYC (pyruvate carboxylase) 
catalyzed reaction (dashed line) is present only in B. subtilis.  PPC (PEP carboxylase) catalyzed reaction (dotted 
line) is present only in E. coli. PCK (PEP carboxykinase) is the gluconeogenesis enzyme which may operate in 
reverse direction in B. subtilis pyk mutant.  
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1.1.5 Proposed Strategies to Improve Cellular Metabolism. 
1.1.5.1 Inducible Pyruvate Kinase 
Based on above experimental results and analysis, both the high level expression of 
pyruvate kinase in the wild-type B. subtilis strain and nil pyruvate kinase activity in the pyk 
knockout mutant may not attained good balance of glycolysis and TCA cycle fluxes, resulted in 
acetate production and slow growth rate, respectively. The complete knockout of pyk resulted in 
high PEP concentration which indirectly lowers the glucose uptake rate. The high PEP 
concentration could be alleviated by controlling the expression of the pyk gene, and thereafter 
possibly restores the cell growth rate of the mutant back to the wild-type level. Therefore, an 
inducible pyk mutant of B. subtilis is to be constructed by replacing the original promoter (a 
DNA sequence that controls the expression of gene) with an inducible one (Pspac, which can be 
induced by IPTG). The expression of PYK can be controlled by the concentration of IPTG.    
1.1.5.2  Inducible Phosphofructokinase 
 Phosphofrucokinase (PFK) catalyzes the ATP-dependent phosphorylation of fructose 6-
phosphate to fructose 1,6-biphosphate. As previously described, the attenuation of pyruvate 
kinase resulted in elevated PEP concentration. PEP is a strong inhibitor of PFK (Blangy et al., 
1968; Evans and Hudson, 1979; Doelle et al., 1982), and high PEP concentration will reduce 
PFK activity, causing reduced glycolytic flux. Therefore, manipulating pfk expression will 
directly affect glycolysis flux. An inducible pfk mutant of B. subtilis will be constructed and the 
effect of pfk expression level on cell growth rate and acetate production will be studied. 
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1.2 FOLIC ACID 
1.2.1 Introduction 
 Folic acid is an important member of B class vitamins. Mammals can not produce folic 
acid by themselves, yet it is an important dietary supplement. Food supplements and microbial 
production in the digestive track are the main sources of folic acid for mammals and birds. 
 A number of developments in diseases related to folic acid deficiency have raised the 
demand for folic acid. A few recent research results have shown that increased folic acid intake 
has been linked with reduced heart disease and lessened incidence of neutral spinal defects in 
newborns. Several other studies have associated diets low in folate with increased risk of breast, 
pancreatic and colon cancer (Giovannucci et al., 1998). These findings have accelerated an 
already booming nutrition industry, and providing abundant and cheap folic acid by improving 
its manufacture process will benefit all the people. 
 Folic acid is now primarily produced via chemical synthesis due to the low yields of folic 
acid produced by current bacterial strains (Miyata et al., 1999; Iwai et al., 1970). However, 
several reasons have prompted new exploration into using microbes for the commercial 
production of folic acid. First, the glutamated and reduced form of the natural vitamin, which 
many bacteria produce (Hintze and Farmer, 1975), is what the digestive system is “designed” to 
process. Unlike synthetic folic acid, the “natural” B vitamin does not require reduction prior to 
being used by the body. Secondly, a single step fermentation route could prove to be more 
environmentally benign than a multi-stage chemical process, if an effective production strain can 
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be developed. Finally, the metabolic capacity of B. subtilis for folic acid production is as high as 
0.161 mole folic acid/mole glucose (Sauer et al., 1998), and the microorganism can be 
engineered to greatly improve the productivity of folic acid. 
 
1.2.2 Biosynthesis of Folic Acid 
 The complete biosynthesis of folic acid in microbes involves many steps and complex 
regulation mechanism. Phosphoenolpyruvate (PEP), glutamate, erthyrose-4-phosphate (E4P) and 
guanosine triphosphate (GTP) are the four precursors of folic acid (Figure 1.3). B. subtilis mutant 
deficient in the enzyme PYK has been found to possess significantly increased PEP and glucose-
6-phosphate pools (Fry et al., 2000; Pan et al., 2006). Both metabolites can fuel folic acid 
synthesis, where PEP is a direct folic acid precursor and glucose-6-phosphate reacts to form the 
precursor E4P. Therefore it is conceivable that a mutation in PYK may potentially increase folic 
acid production. This also offers a good start strain to be further engineered for enhanced folic 
acid production.  
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Figure 1.3. Biosynthesis pathway of folic acid. 
The schematic graph shows the flow of metabolites and the genes that encode the enzymes involved in folate. The 
abbreviation for the metabolites are PEP (phosphoenolpyruvate); E4P (erythrose-4-phosphate), DAHP (3-deoxy-D-
arabino-heptulosonate-7-phosphate), PABA (para-aminobenzoic acid), Phe (phenylalanine), Tyr (tyrosine), Trp 
(tryptophan) and GTP (guanosine triphosphate).  
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1.2.3 Review of Efforts to Increase Folic Acid Production in Microbes 
In the past decade, relatively limited efforts have been put on enhancing folic acid 
production in microorganisms.  A few genetic engineering approaches have been investigated to 
enhance folic acid production by amplifying the expression of genes involved in folic acid 
biosynthesis. One study shows that over-expression of folk which encodes the first enzyme GTP 
cyclohydrolase I in the folate biosynthesis pathway in Lactococcus lactis increased extracellular 
folate production by 800% (Sybesma et al., 2003). It was shown that folK might encode the rate-
limiting enzyme (Pyrophosphokinase) in B. subtilis strains that over-express each of the five 
genes (sul, folA, folK, mtrA, and folC) (Eichler et al., 1997). However, it is conceivable that 
amplifying all five genes could further elevate folic acid production. Another study with a few 
bacteria including one B. subtilis strain indicated that para-aminobenzoic acid (PABA) pathway 
may be rate limiting based on the experimental results that addition of PABA in the medium 
dramatically increased folic acid production (Miyata et al., 1999). Recent work in our group 
showed that a combination of mutations in over-expressing aroH, disrupting mtrB and trpC2, 
and down-regulating pyk, resulted in 8-fold increase in folic acid production as compared to B. 
subtilis 168 (Zhu et al., 2005). mtrB encodes the tryptophan RNA-binding attenuation protein 
(TRAP) which has been found to terminate the transcription and translation of the folate operon.  
 
. 
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1.3 RECOMBINANT PROTEIN PRODUCTION 
1.3.1 B. subtilis as a Host for Recombinant Protein Production 
The gram-positive bacterium B. subtilis has been extensively used in the food industry 
due to its safety (generally recognized as safe by the FDA) and high secretion capacity of native 
enzymes. The majority of commercial available enzymes are produced by B. subtilis (Westers et. 
al., 2004), however, E. coli is still currently the most commonly used bacterial host for industrial 
production of heterogeneous pharmaceutical proteins as it is the best characterized bacterial 
strain and the availability of various expression vectors facilitates high levels of protein 
production in E. coli. The application of B. subtilis for heterogeneous protein production is 
limited by its low productivity due to increased proteolysis and eventual sporulation. A few 
recent developments, however, have made B. subtilis an attractive host for heterologous protein 
production. First, the availability of protease-deficient strains of B. subtilis has greatly improved 
the productivity and stability of secreted proteins (Wong et al., 1995; Wu et al., 1991 and 2002). 
Second, asporogenous strains are now available (Oh et al., 1995; Pierce et al., 1992), which 
further improves the productivity of desired products. Third, the complete genome sequence of 
B. subtilis is known (Kunst et al., 1997) and the host strain can be optimized for hetorologous 
proteins production using modern genetic engineering techniques. Furthermore, the recently 
developed high throughput analysis technologies such as DNA microarry and 2-D gel 
electrophoresis have greatly sped up developmental work in B. subtilis. 
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1.3.2 Detrimental Effect of Acetate on Recombinant Protein Production 
As being addressed previously, most bacteria including B. subtilis produces a significant 
amount of acetate when the common carbon source glucose is employed. The accumulation of 
acetate not only inhibits cell growth (Luli and Stohl, 1990), it was also reported to have 
detrimental effect on recombinant protein production (George et al., 1992; Jensen and Carlsen, 
1990; Hahm et al., 1994). Many acetate-reduction strategies have been found to confer increases 
in heterologous protein production (Bauer et al., 1990; De Anda et al., 2006; Kim and Cha, 2003; 
San et al., 1994; Vemuri et al., 2006). The majority of these efforts have been focusing on the 
gram negative E . coli and many approaches have achieved reduced acetate production as well as 
enhanced recombinant protein production (De Anda et al., 2006; March et al., 2002; Vemuri et 
al., 2006), however, less information is available for B. subtilis. 
 
1.3.3 Effect of pyk Expression on Recombinant Protein Production 
Our previous study with B. subtilis showed that down-regulating pyk significantly 
reduced the acetate production and a good balance of fluxes between glycolysis and the TCA 
cycle can be attained at an appropriate pyk expression level (Fry et al., 2000; Pan et al., 2006). 
Therefore, we hypothesize that a strain with lower pyk expression may be beneficial to 
recombinant protein expression in B. subtilis based on our following attained observations: (1) 
down-regulating pyk significantly reduced formation of toxic by-products (Fry et al., 2000; Pan 
et al., 2006), and  (2) production of recombinant protein was dramatically enhanced in 
continuous culture of B. subtilis with dual feeding of glucose and citrate (Vierheller et al., 1995) 
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which corresponds to a low pyruvate kinase status (Goel et a., 1995; Lee et al, 1997; 
Phalakornkule et al., 2000). In this study, we will investigate how pyk mutation will affect 
recombinant protein production in B. subtilis. GFP+ (Scholz et al., 2000) will be selected as a 
model protein due to its brightness (130-fold brighter than wild type GFP) and ease of detection 
by fluorescence spectrometry. In addition, GFP+ is very stable, which can minimize the effect of 
degradation. 
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2.0  MATERIALS AND METHODS  
2.1 CELL CULTURING 
2.1.1 Strains 
B. subtilis 168 (wild-type or WT), 1A96, 1A99, 1A92, 1A330 were obtained from 
Bacillus Genomic Stock Center (BGSC, Columbus, OH). Competent Escherichia coli strain 
DH5a was purchased from Invitrogen (Carlsbad, CA), and used for the construction of plasmids 
throughout this work. The construction of inducible pyk mutant of B. subtilis (iPYK mutant) was 
briefly described elsewhere (Zhu et al., 2003) and in section 2.3 in detail. The construction of 
inducible pfk was described in section 2.3. The construction of GFP+ production strains 
WTpGFP+ (WT bearing plasmid pGFP10) and MTpGFP+ (iPYK mutant bearing plasmid 
pGFP10) was also described in section 2.3. B. thuringiensis was obtained from American Type 
Culture Collection (ATCC No. 35646). All the strains and plasmids used in this work were listed 
in Table 1. 
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Table 1. Strains and plasmids used in this work  
 
Strains and plasmids Description Source or 
reference 
Strains   
B. subtilis 168 trpC2 BGSC* 
B. subtilis 1A96 trpC2 pheA BGSC 
B. subtilis 168 + iPYK trpC2 pyk (inducible), Ermr Zhu et al., 2005 
B. subtilis 168 + iPFK trpC2 pfk (inducible), Ermr This study 
B. subtilis 168 + pGFP10 trpC2 gfp+, Kanr This study 
B. subtilis 168 + iPYK + pGFP10 trpC2 pyk (inducible) gfp+, Ermr Kanr This study 
BSTZ 0408 trpC2 mtrB::erm Zhu et al., 2005 
BSTZ 0410 trpC2 aroH Zhu et al., 2005 
BSTZ 0412 trpC2 aroH tktA Zhu et al., 2005 
BSTZ 0419 trpC2 mtrB::cm pyk(Ind) Zhu et al., 2005 
BSTZ 0425 trpC2 aroH pyk(Ind) Zhu et al., 2005 
BSTZ 0437 trpC2 pyk(Ind) Zhu et al., 2005 
B. subtilis 1A99 ilvA3 trpC2 odhA1 BGSC 
B. subtilis 1A92 arg(GH)2 aroG932 bioB141 sacA321 BGSC 
B. subtilis 1A330 aroG932 bioB141 BGSC 
   
E.coli DH5a Cloning strain Invitrogen 
   
B. thuringiensis Berliner 35646 ATCC ** 
   
Plasmids   
pMutin4 Ampr Ermr BGSC 
pRB374 Ampr Kanr Brückner, 1992 
pMTPYK Ampr Ermr;  Zhu et al., 2005 
pMTPFK Ampr Ermr This study 
pMN402 AmprHygr BGSC 
pGFP10 Ampr Kanr This study 
pRA1 Ampr Kanr, aroH Zhu et al., 2005 
pRAT2 Ampr Kanr, aroH tktA Zhu et al., 2005 
pVp2 Ampr Ermr, contains Ermr cassette 
between 5’ and 3’ fragments of mtrB 
Yang et al., 1995 
 
*BGSC: Bacillus Genomic Stock Center (Columbus, OH). 
**ATCC: American Type Culture Collection (Manassas, VA) 
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 2.1.2 Media 
 Luria-Burtani (LB) Lennox Medium is a rich medium used for culturing bacteria. 25 g/L 
LB medium contains 10 g/L Tryptone, 5 g/L yeast extract and 10 g/L sodium chloride.  
Glucose minimal medium was used as the basic culture medium for both B. subtilis and 
B. thuringiensis. 1 liter of glucose minimal medium contains: 1 g NH4Cl, 1.0g KH2PO4, 2.72 g 
K2HPO4, 0.284 g Na2SO4, 0.17g NaNO3, 0.15 g KCl, 0.049 g MgCl2·6H2O, 2.16 mg 
FeCl3·6H2O, 0.015 MnCl2·4H2O, 0.022 g CaCl2·6H2O. The concentration of glucose and citrate 
used in each experiment were noted in the text. In bioreactor cultures, 2 mL/L 10% antifoam B 
was added to control the foaming. 
C medium is a buffered minimal medium used to culture B. subtilis (Aymerich, et al., 
1986). 1 liter of C medium contains: 16 g K2HPO4·3H2O, 4.1 g KH2PO4, 3.3 g (NH4)2SO4, 0.12 
g MgSO4·7H2O, 1.7 mg MnSO4·H2O, 22 mg C6H11FeNO7, 1 mL trace element solution, and 0.1 
g L-Tryptophan. The culture medium was supplemented with a carbon source of glucose or 
glycerol, and the amount of carbon source was described in the text. Trace element solution was 
prepared by adding the following salts to 1 L of 1 M HCl: 4.87 g FeSO4·7H2O, 4.12 g 
CaCl2·2H2O, 1.50 g MnCl2·4H2O, 1.05 g ZnSO4·7H2O, 0.30 g H3BO3, 0.25 g Na2MoO4·2H2O, 
0.15 g CuCl2·2H2O, and 0.84 g Na2EDTA·2H2O (Bühler, et al., 2002).  
 Semi-rich media were prepared by adding appropriate amount of LB medium to either 
glucose minimal medium or C medium. The amount of LB medium, glucose, citrate, and 
glycerol were described in the text.  
 
 24 
The culture media may contain appropriate antibiotics for the culture of recombinant 
strains which have resistance to specific antibiotic(s). Antibiotics were supplemented in the 
media at the following concentrations: ampicillin, 100 mg/L; chloramphenicol, 5 mg/L; 
kanamycin, 10 mg/L; and erythromycin, 0.5 mg/L.  
  
2.1.3 Batch Cultures 
 Batch cultures were conducted in either baffled 300 ml shake flasks or 1 L bioreactors. 
The cultivation temperature is 37 oC for B. subtilis and E. coli, and 30 oC for B. thuringiensis. 
Aeration is 1.0 ~ 2.0 L/min. The shaking speed with shake flask culture is 200 rpm, and the 
agitation speed with bioreactor culture is 500 rpm.   
2.1.4 Reactor Setup and Continuous Cultures 
1-L Fermentation vessel (Applikon, Foster City, CA), with a working volume of 500 mL, 
was used throughout this study. The reactor setup for continuous culture is briefly shown in 
Figure 2.1. Initially, the bioreactor was operated batch-wise until the cells reached mid-
exponential growth. Thereafter, fresh medium was fed into the bioreactor at the selected feed rate 
with a peristaltic pump. The culture was assumed to reach steady-state after more than five 
retention times when no variations in optical density and residue glucose were observed. The air 
flow rate was set at 2 L/min, and the pH was controlled between 6.5 and 7.0 by adding 1N KOH 
with a Chemcadet PH Meter/Controller (Cole-Parmer, Chicago, IL). The temperature was 
maintained at 37 ºC for B. subtilis and 30 ºC for B. thuringiensis by using a water circulator 
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(HAAKE, Austin, TX). Inocula were grown in LB broth overnight, and the inoculation size was 
2.5% of the working volume.  
 
 
 
 
 
 
Figure 2.1. Schematic diagram of continuous culture system. 
D: dilution rate (D = F/V), µ: specific growth rate (µ = (1/X)*dX/dt), F: flow rate, V: volume, X: cell density, P: 
product concentration. When the culture reaches steady state, D = µ. 
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2.2 ASSAYS 
2.2.1 Measurement of Cell Density 
 Samples were taken from the shake flask or bioreactor cultures at intervals. Cell density 
was determined by means of optical density (OD), based on their proportional relationship (1 
OD660 = 0.35 g cell dry weight/L). Optical density was measured off-line at 660 nm using a 
Lambda-6 UV/Vis Perkin Elmer spectrophotometer (Perkin Elmer, Norwalk, CT). The optical 
density measurements are linear within the range of OD660 = 0.05 to 0.5, therefore, samples with 
higher cell densities were diluted in water before the measurement. 
2.2.2 Enzymatic Assay of Glucose  
 Glucose concentration was assayed using a Glucose (HK) Assay Kit (Sigma GAHK20), 
which is based on the principle of an end-point assay. 
  ADPPhosphateeGluATPeGlu Hexokinase +−−⎯⎯⎯ →⎯+ 6coscos
  NADHconatePhosphogluNADPG PDHG +−⎯⎯ →⎯+−− 66 6
Glucose is phosphorylated by adenosine triphosphate (ATP) in the reaction catalyzed by 
hexokinase. Glucose-6-phosphate (G6P) is then oxidized to 6-phosphogluconate in the presence 
of oxidized nicotinamide adenine dinucleotide (NAD) in a reaction catalyzed by glucose-6-
phosphate dehydrogenase (G6PDH). During this oxidation, an equal-molar amount of NAD is 
reduced to NADH. The consequent increase in absorbance at 340 nm is directly proportional to 
glucose concentration. In the process of culture, a glucometer Elite (Byer, Elkhart, IN)) was 
frequently used to quick monitor the glucose utilization.  
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2.2.3 Organic Acids 
Organic acids were measured using HPLC or enzymatic assay kits. A 1 mL sample of 
culture medium was collected and cells were immediately removed using 0.45 µm syringe filter.  
Acetate and pyruvate were measured using a Waters HPLC equipped with UV/Vis monitor 
(Waters, Milford, MA) after being eluted from an organic acid analysis column (Bio-Rad, 
Richmond, CA) with 5mM H2SO4. The column was maintained at 50 °C and the isocratic flow 
rate was 0.7 ml/min. Acetate, as well as other acids, were detected by absorbance at 210 nm. 
Acid concentrations were calculated from comparing the peak area of corresponding acid with 
respect to the standard curves. Citrate and lactate were measured by enzymatic assay kits (r-
Biopharm Inc., SouthMarshall, MI).  
2.2.4 Enzyme Activities  
Cell extract was prepared according the procedure used by Fisher & Magasanik (1984) 
with some minor modifications. Samples were taken during the mid-exponential phase for the 
batch cultures. Cells were harvested by centrifugation at 4 oC for 3 minutes at 14000 g.  The 
pellet was washed twice with PBS (no calcium) buffer, and then disrupted via incubation in lysis 
buffer (20 mM Tris HCl  pH 8.0, 10 mM EDTA pH8.0, 100 mM KCl, 20 g/L sucrose, 400 mg/L 
lysozyme, and 100 mg/L Dnase) for 10 ~ 20 minutes. The debris was then removed by 
centrifugation at 4 oC for 10 minutes at 14000 g, and the supernatant was used for total protein 
and enzyme assay. 
 The total protein was determined by Pierce BCA protein assay kit according to the 
protocol provided by the provider. For pyruvate kinase assay, the standard assay mixture 
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contains in a final volume of 1 mL: 31 mM K2HPO4 (pH = 7.5), 6.7 mM MgSO4, 2 mM ADP, 
0.24 mM NADH, 22 unit of crystalline lactate dehydrogenase, 10 mM Phosphoenolpyruvate 
tricyclohexylammonium salt, and 100 µL of crude cell extract.  Pyruvate kinase was assayed at 
room temperature by determining the decrease of OD at 340 nm (Pan et al., 2006). Each 
measurement was performed in triplicate.  
Phosphofructokinase was assayed according to procedure given by Andersen et al., 
2001). The final concentrations of the components of the reaction mixture were 87 mM Tris-HCl 
(pH8.0), 1 mM ATP, 1 mM fructose-6-phosphate, 10mM MgCl2, and 10 mM NH4Cl, and 0.2 
mM NADH; a mixture of 0.3 unit of triosephosphase isomerase, 1 unit of glycerol-3-phosphate 
dehydrogenase, 0.3 unit of aldolase, and 1 mM ATP was used to initiate the reaction. 
Measurement of acetate kinase activity was determined at room temperature according to 
the protocol from Sigma Co (Sigma, St Louis, MO) which is based on the method described by 
Bergmeyer et al. (1983). The assay mixture contains in a final volume of 1 mL: 59.3 mM 
Triethanolamine Buffer (pH = 7.6), 200 mM NaOAc, 6.67 mM MgCl2, 0.11 mM NADH, 6.07 
mM ATP, 1.87 mM PEP, 11.67 unit Pyruvate Kinase, 16.67 unit Lactate Dehydrogenase and 
16.67 unit Myokinase. One unit of acetate kinase activity was defined as the production of 1.0 
µmole acetyl phosphate per minute at pH 7.6 at 25 degree C. 
2.2.5 Measurement of the Concentration of Intracellular Metabolites 
 Cells were grown to the exponential growth stage in shake flasks, and cell extracts were 
prepared using the formic acid extraction method as described previously (Fry et al., 2000). 
Briefly, the mid-exponential culture was immediately chilled to 0~4°C by immersing and 
swirling the flask in liquid nitrogen. The nearly frozen liquid was then transferred to pre-cooled 
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centrifugation tube and the cells were harvested by centrifugation at 4°C for 5 minutes with a 
superspeed refrigerated centrifuge. The cell pellet was resuspended in 1 N cold formic acid and 
incubated at 4°C for 1 h. Cell debris was then removed by centrifugation. The supernatant was 
then lyophilized and resuspended in 0.2% of the original culture volume with distilled water. The 
assay of glucose-6-phosphate (G6P), phosphoenolpyruvate (PEP), pyruvate and fructose-1,6-
biphosphate (FBP) was performed as described by Lowry and Passonneau (1972). 
 
G6P is measured using an end-point enzymatic assay involving the following reactions: 
  NADPHtoneGluconolacPNADPPG PDHG +−−⎯⎯ →⎯+ 66 6
  gluconatePOHtonegluconolacP −−⎯→+−− 66 2
The formation of NADPH is proportional to the amount of G6P in the sample. NADPH formation is 
monitored by measuring absorbance at 340 nm. The first reaction is catalyzed by G6P dehydrogenase 
(G6PDH), and the second reaction is nonenzymatic. The assay mixture in the cuvette contained the 
sample, buffer (25 mM Tris, 25 mM Tris-HCl, pH7.5), 50 µM NADP, 0.1 mM ditiothreitol, 0.02 U/mL 
G6P dehydrogenase and up to 10-11 mM G6P (from sample or standard). 
 
PEP was measured using an enzymatic assay involving the following two reactions: 
ATPPyruvateADPPEP PYK +⎯→⎯+  
NADLactateNADHPyruvate LDH +⎯⎯→⎯+  
The decrease in NADH is proportional to the amount of PEP in the sample. NADH utilization is 
monitored by measuring absorbance at 340 nm. The first reaction is catalyzed by pyruvate kinase, and the 
second reaction is catalyzed by lactate dehydrogenase. The assay mixture contains 10 µM NADH, 10 mM 
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hydrazine HCl, 0.2 U/mL lactate dehydrogenase (LDH), 0.15 U/mL pyruvate kinase (PYK), 2 mM MgCl2, 
200 µM ADP and up to 10-11 mM PEP (from sample or standard). The reaction was started by adding 
lactate dehydrogenase. An initial reading is made, and then add pyruvate kinase. 
 
Pyruvate is measured using the reaction: 
NADLactateNADHPyruvate LDH +⎯⎯→⎯+  
The reaction mixture contains 30 mM phosphate buffer (pH7.0), 10 mM NADH and 0.2 mg/mL lactic 
dehydrogenase. The reaction is started by adding the enzyme after the sample is in and an initial reading 
is made. The end point is reached in approximately 5 minutes. 
 
FBP was measured by coupling aldolase, triose-phosphate isomerase, and glycerophosphate 
dehydrogenase and measuring the decrease in fluorescence of NADH after completion of the reaction.  
PhydeglyceraldePcetonedihydroxyaFBP aldolase −+−⎯⎯ →⎯  
PhydeglyceraldePcetonedihydroxya isomerasePtriose −⎯⎯⎯⎯⎯ →⎯− −−  
+++−−⎯⎯⎯⎯⎯ →⎯− HNADHglyceratePPhydeglyceralde genaseGAPdehydro 3  
The reaction mixture contains 85 mM TEA buffer with 4.2 mM EDTA (pH7.6), 0.24 mM NADH, 
0.331U/mL aldolase, 3.492 U/mL triosephosphate isomerase, 0.395 U/mL glycerophosphate 
dehydrogenase, and extract sample/standard in a final volume of 1 mL. 
 31 
2.2.6 Folic Acid Measurement 
 Both extracellular and intracellular concentrations of folic acid were assayed. Samples 
taken at the intervals during the cultivation were centrifuged, and the supernatant was filtered 
with 0.02 µm syringe filter and diluted 10~100 times for the measurement of extracellular folic 
acid concentration. The cell pellet were resuspended and lysed with a French press, passed 
through a 0.02 µm filter, diluted 50 to 200 times for the measurement of intracellular folic acid 
concentration.  
 Microbial bioassay (Difco Manual, 11th edition) was then used to measure the folic acid 
concentration. A stock culture of the test strain ATCC 7469 which is an auxotroph of folic acid 
was prepared in a 15-mL tube with 10 mL Micro Inoculum Broth. These inocula were incubated 
at 37°C for 18 hr. Under aseptic conditions, the cultures were centrifuged to sediment the cells 
and then washed three times with the folic acid assay medium. The cells were then resuspended 
in folic acid free medium and incubated at 37°C for additional 5~8 hours. The cells were diluted 
100-fold, and 10 µL of this suspension was used to inoculate each of the assay tubes (in a 2-mL 
microcentrifuge tube). To each tube, 1 mL double strength folic acid assay medium and 1 mL of 
sample were added. The optical density of the assay tubes was measured after 18 to 24 h of 
incubation at 37°C. It was essential that a standard curve be constructed for each separate assay. 
The standard curve was generated by using 0.0, 0.05, 0.1, 0.15, and 0.2 ng of folic acid per assay 
tube (2 ml). Optical density was measured using a Lambda 6 Perkin- Elmer spectrophotometer 
(Perkin-Elmer, Norwalk, CT) at 600 nm.  
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2.2.7 GFP Expression Measurement 
Cells were sampled periodically along the culture, diluted with water to OD around 0.1 
and used to measure the fluorescence. Fluorescence intensity was detected at room temperature 
using a Perkin Elmer luminescence spectrometer LS50B, with an excitation wavelength of 491 
nm, an emission wavelength of 512 nm (Scholz et al., 2000), and a slit width of 5 nm. For the 
GFP+ measurement in the medium, the samples were centrifuged at 21,000g for 8~10 minutes, 
and the fluorescence of the supernatant was measured. Triplicate measurements were obtained 
for each sample, and average values are reported. 
Flow Cytometry was also employed to measure fluorescence per cell. 1 mL culture was 
taken during the cultivation and cells were collected by centrifugation. The pellet was then 
washed once using cold PBS buffer before being applied to FACScan (Becton Dickinson, San 
Jose, CA) to analyze the expression of GFP+. The data analysis was performed with CellQuest 
Pro (Becton Dickinson, San Jose, CA) software.  
2.2.8 Plasmid Purification and Plasmid Copy Number Measurement 
 To determine the copy number of different strains, cells were grown in flask cultures and 
same amount of cells from each culture was harvested in the mid-exponential phase. Plasmid 
DNA was then isolated using a Qiagen plasmid purification kit (Catalog No. 27106) according to 
the protocol specifically developed for B. subtilis (Appendix B). The pelleted cells were 
resuspended in 250µL Buffer P1 containing 1 mg/mL lysozyme and incubated at 37 oC for 10 
min. The rest steps followed the protocol provided with product. Plasmid concentration was 
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calculated based on the absorbance at 260 nm (A260nm), and purity was checked by absorbance 
ratio of A260nm/A280nm which should be around 1.8 and by agarose gel analysis. The plasmid 
copy number is defined as the number of plasmid copies per cell. Cell number was counted using 
a Spencer hemacytometer under a phase-contrast microscope. The calculation of plasmid copy 
number was based on the calculation of the molecular weight of the plasmid relative to the cell 
number. Average molecular weight of a base was assumed to be 309 g/mol (Neidharddt et al., 
1990).  
2.2.9 Gene Expression Measurement by Quantitative RT-PCR  
mRNA was extracted from 1x107 cells at mid-log phase using a mRNA capture kit from 
Qiagen (Catalog No. 70022). The RNA concentration of each sample was determined by 
absorbance at 260 nm using a Lambda-6 UV/Vis Perkin Elmer spectrophotometer. The purity 
was checked by absorbance ratio of A260nm/A280nm which should be around 1.8 and by 
agarose gel analysis. The pair of subcloning primer gfpF and gfpR was used to detect GFP+ 
mRNA using a one-step RT-PCR kit from Qiagen (Catalog No. 210210). A Kodak 1D imaging 
analysis system was utilized to semi-quantify the expression level of GFP+ mRNA in various 
samples.  
2.2.10 Spore Counting 
 Sporulation was monitored under the phase-contrast microscope at a magnification of 
×1000. Collected culture was diluted and cells and free spores were counted using a Spencer 
hemacytometer. 
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2.2.11 Measurement of Protein Using SDS-PAGE 
Protein profile was determined using SDS-PAGE as described elswhere (Banerjee-
Bhatnagar, 1998). 1 mL culture was centrifuged, and the pellets were resuspended in 10 mM 
Tris-HCl, pH 7.5 buffer containing 1 mM PMSF to same cell density, mixed with 2× 
solubilization buffer (Laemmli’s sample buffer containing 8 M urea), boiled for 5 minutes and 
25 µL was loaded on a 10-12% SDS-polyacrylamide gel.  
2.3 CLONING 
2.3.1 Construction of Inducible Pyruvate Kinase (iPYK) Mutant 
 The primers BspykF (5’-CCGGATCCGAAGATTTCAGAAGGAAGTG AACC-3’) and 
BspykR (5’-CCGGATCCGGAATTTCCACACCTAAGTCTCC-3’) were designed using the 
sequence of the B. subtilis pyk gene obtained from GenBank. These primers were designed to 
include BamHI restriction sites (shown in bold) to facilitate cloning, and used to amplify a 700-
bp fragment from B. subtilis genomic DNA by PCR with 50 ng of genomic DNA in a final 
volume of 50 µL containing deoxyribonucleoside triphosphates (0. 5mM each), oligonucleotides 
(50 pM), and 1 U of Pfx polymerase (Invitrogen, Paisley, Great Britain). Amplification was 
performed in a GeneAmp PCR system 2400 (Perkin Elmer, Norwalk, CT ) with 35 cycles of 
denaturation at 94 oC for 30 s, annealing at 50-60 oC for 30 s, and elongation at 68 oC for 1 to 3 
minutes. The PCR amplified fragment was then digested, purified and cloned into plasmid 
pMutin4 (Vagner, 1998) as shown in Figure 2.2, and the resulted recombinant plasmid 
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(pMTPYK) was purified again, and transformed into competent E. coli DH5a (Invitrogen, 
Paisley, Great Britain). Isolation of E. coli plasmid DNA was performed using Promega 
Wizard® SV Gel and PCR Clean-Up System. The purified recombinant Plasmid pMTPYK was 
then transformed into competent B. subtilis cells, and transformants were selected on antibiotic 
medium plates containing 0.3 mg/L erythromycin. The mutants were analyzed by PCR to 
confirm the integration of a single copy of the plasmid into the target gene on the chromosome, 
using a strategy similar to that described previously (Pragai and Harwood, 2000). Additionally, 
to identify colonies who respond to IPTG induction, the harvested colonies were further patched 
on two glycerol minimal medium plates, one without IPTG and the other contains 0.2 mM IPTG.  
The colonies that grew well on both plates were discarded. For an inducible pyk mutant, there 
shall be very little or no visible growth on the glycerol minimal medium plate without IPTG and 
good growth on the glycerol minimal medium plate with 0.2 mM IPTG.  The very slow growth 
rate for the inducible pyk mutant without IPTG on glycerol minimal medium plate can be due to 
the action of phosphoenolpyruvate (PEP) carboxykinase, which can operate in the reverse 
direction from PEP to oxaloacetate upon knockout of pyruvate kinase in B. subtilis (Zamboni et 
al., 2004). Another possible reason for slow growth rate on glycerol in the absence of induction 
may be the leaky expression of pyk.  Colonies were identified that showed very good growth 
with 0.2 mM IPTG (fully developed after two days) but grew on glycerol minimal medium at 
very slow rate (tiny colonies were observed in the glycerol minimal medium plate without IPTG 
after 5 days culture). 
 Inducible PFK mutant was constructed in a same way as inducible PYK mutant except 
that the primers BspfkF (5’-CCGGATCCGAAGATTTCAGAAGGAAGTG AACC-3’) and 
BspfkR (5’-CCGGATCCGGAATTTCCACACCTAAGTCTCC-3’) were used in the cloning.  
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Figure 2.2. Construction of inducible pyk mutant. 
The vector is integrated into pyk gene of wild type B. subtilis chromosome by a single crossing-over event. Arrows 
indicate direction of transcription, broken arrows denote the promoter of the pfk-pyk operon and Pspac, and the 
lollipop strand is for the transcription termination. 
 
 
2.3.2 Construction of Plasmid with gfp+ 
B. subtilis plasmid pGFP10 was created by cloning gfp+ gene from vector pMN402 
(Bacillus Genomic Stock Center, Columbus, OH) to the shuttle vector pRB374 (Brückner, 1992), 
using primers gfpF (5’-GGC CAT CTGCAG GAA GGA GAT ATA CAT ATG GCT-3’) and 
gfpR (5’-GGC CAT GAA TTC GCT CGA ATT CAT TAT TTG TAG-3’). These primers were 
designed to include Pst I and EcoR I restriction sites (shown in bold) to facilitate cloning. The 
recombinant plasmid was amplified in E. coli DH5a, isolated and transformed into competent B. 
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subtilis cells (wild-type 168 and inducible pyk mutant), and transformants were selected on 
antibiotic medium plates containing 10 mg/L kanamycin for wild-type 168 and 10 mg/L 
kanamycin plus 0.5 g/L erythromycin for the pyk mutant. The transformants were confirmed by 
restriction digestion of plasmid prepared from the culture, as well as the DNA sequencing. 
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3.0  CHARACTERIAZATION OF IPYK MUTANT OF B. SUBTILIS 
3.1 INTRODUCTION 
 The gram positive bacterium B. subtilis has long been used for the chemical production. 
One common problem happened during fermentation is the production of acidic by-products 
which limits the product yield and overall productivity. Previous work in our group has 
identified Pyruvate kinase as a mutation target to reduce acids production (Goel et al., 1995 and 
1999; Lee et al., 1997; Phalakornkule et al., 2000). The knockout of pyk gene in B. subtilis 
eliminated acetate formation; however, a dramatically reduced cell growth in the glucose 
minimal medium was observed (Fry et al., 2000). Addition of pyruvate in medium restored the 
cell growth rate back to that of wild-type level, which indicates that the complete abolishment of 
pyruvate kinase may result in limited supply of pyruvate to TCA cycle. These findings indicate 
that the expression level of pyk may affect both cell growth rate and acetate production. To 
obtain an insight of the metabolic responses upon a change in pyk expression, an inducible pyk 
mutant of B. subtilis was constructed (Zhu et al., 2005; Pan et al., 2006). The relationship among 
Pyruvate Kinase (PYK) activity, cell growth rate, and acetate formation of the inducible PYK 
(iPYK) mutant at different induction levels were examined in batch cultures. The results 
illustrated that a wide range of pyruvate kinase activities in the cultures of the iPYK mutant can 
be displayed by varying in vitro IPTG concentration. Measurements of cell growth rate and 
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acetate formation of the iPYK mutant at different induction levels revealed that a PYK activity 
of about 12% of wild-type allows for good growth rate (0.4 hr-1 versus 0.63 hr-1 of wild-type), 
low acetate production (0.26 g/L versus 1.05 g/L of wild-type). 
3.2 RESULTS 
3.2.1 Pyruvate Kinase Activities at Various Concentration of IPTG in Batch Cultures. 
The PYK activities possessed by the wild-type and iPYK mutant at several 
concentrations of IPTG were measured in batch cultures. Samples were taken during the mid-
exponential phase. As given in Table 2, the specific PYK activity exhibited by the iPYK mutant 
without IPTG present is 0.48 mmol/(g cell·hr), which is only about 3% of that of the wild-type. 
The PYK activity of iPYK mutant without IPTG present in the medium is similar to that of the 
pyk knockout mutant (data not shown), indicating the leaky expression of PYK in the iPYK 
mutant is very low. The low leakage concurs with the design of the iPYK mutant. A pMUTIN4 
plasmid was used whose promoter Pspac was strongly repressed. Strong repression is provided 
by using an “oid” operator (Lehming et al., 1987) to facilitate the binding of LacI, and two 
additional strong terminators (t1t2 from rrnB) to minimize the transcriptional read-through. Both 
design elements greatly increased the repression of Pspac in the absence of IPTG (Vagner, 1998) 
as was confirmed by the nearly zero value of the pyruvate kinase activity without induction 
(Table 2).   
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The PYK activity increased significantly when the IPTG concentration was raised from 
0.0 to 0.05 mM, and then from 0.05 to 0.2 mM.  For the culture supplemented with 1.0 mM 
IPTG, the pyruvate kinase activity of iPYK mutant reached 18.24 mmol/(g cell·hr), which is 
similar to the wild-type activity (16.32 mmol/(g cell·hr)). Therefore, the iPYK mutant displays a 
wide-range of PYK activity to meet the need of this study.  
 
 
 
Table 2. PYK activity, cell growth rate, acids of wild-type and inducible PYK of B. subtilis  
  WT iPYK Mutant 
IPTG (mM) 0 0 0.05 0.2 1 
PYK activity 
(mmol/(g cell·hr)) 16.32 ± 1.92 0.48 ± 0.048 5.02 ± 1.28 12.48 ± 1.25 18.24 ± 2.64 
Growth rate (hr-1) 0.63 ± 0.022 0.14 ± 0.003 0.40 ± 0.036 0.58 ± 0.007 0.60 ± 0.165 
Acetate (g/L) 1.05 ± 0.130 0.02 ± 0.015 0.26 ± 0.065 0.80 ± 0.018 1.21 ± 0.215 
Pyruvate (g/L) 0.38 ± 0.023 0.00 0.06 ± 0.011 0.29 ± 0.017 0.45 ± 0.032 
Lactate (g/L) 0.53 ± 0.028 0.00 0.12 ± 0.015 0.41 ± 0.021 0.67 ± 0.033 
 
Both strains were cultivated in glucose minimal medium with 8g/L glucose and iPYK mutant cultures have various 
dosage of IPTG in the medium. The acetate concentration, PYK activity, and growth rate were measured in three 
independent experiments.  The standard deviations are relatively small as given in the Table.  
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3.2.2 Cell Growth Rate & Acetate Production in Batch Cultures of Wild-type & iPYK 
Mutant at Different Induction Levels 
The results of cell growth in batch cultures with 8 g/L glucose were shown in Figure 
3.1A. The iPYK mutant in the absence of IPTG grew very slowly in the glucose minimal 
medium with a growth rate of about 0.14 hr-1, which is comparable to the pyk knockout mutant 
(Fry et al., 2002). When the medium was supplemented with 0.05 mM IPTG, the growth rate 
was significantly increased to 0.42 hr-1.  With IPTG concentration of 0.2 mM, the iPYK mutant 
grew nearly as fast as wild-type (ca 0.63 hr-1). Increasing the IPTG concentration from 0.2 to 1.0 
mM did not increase the cellular growth rate, though the PYK activity increased by almost 50% 
(Table 2). In one experiment the wild type cells were grown in the presence of 1 mM IPTG as a 
control.  As expected, there was no effect of IPTG on growth rate of wild type culture (data not 
shown). 
The concentrations of acetate, lactate, and pyruvate were measured in the last three points 
on the growth curves of Figure 3.1A. In each case there was a point that displayed the highest 
concentrations of these by-products. The concentrations of acetate, lactate, and pyruvate found in 
the points corresponding to the maximum concentrations were given in Table 2. The results 
indicate that the level of PYK expression influences both cellular growth rate and acetate 
formation, but how acid formation and growth rate depend on PYK activity differs. Acetate 
production increases consistently with PYK activity. In contrast, the cellular growth rate reaches 
a plateau with respect to PYK expression. This disparate behavior provides an advantage because 
one may control the acetate production at a low level while still maintaining high cell growth 
rate. This is the case for the iPYK mutant cultured in the presence of 0.05 mM IPTG, which 
produced 83% less acetate than the wild-type yet maintained a growth rate that is only 30% 
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lower than the wild-type. In addition to acetate, the concentrations of secreted lactate and 
pyruvate were also substantially lower in the iPYK mutant grown with 0.05 mM IPTG than the 
wild-type (Table 2).  The cell density of the iPYK mutant grown with 0.05 mM IPTG is about 
20% higher than the wild type culture (Figure 3.1A).   
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Figure 3.1. Cell growth of wild-type (WT 168) and inducible PYK mutant (iPYK MT) in glucose 
minimal medium with 8g/L glucose. 
The values are the average of three independent experiments, and the standard deviation is less than 15%.  The 
residual glucose concentration at the end of growth phase was negligible. 
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3.2.3 Intracellular Metabolite Pools and Acetate Kinase Activity 
Because glucose was completely consumed at the end of both cultures (iPYK mutant 
cultured in the presence of 0.05 mM IPTG and the wild-type) as shown in Figure 3.1B, the 
glucose consumption rate will be lower for the iPYK mutant with 0.05 mM IPTG than the wild 
type due to its lower growth rate. Thus, one factor contributing to the lower acetate formation 
will be the lower glycolytic flux. However, it is possible that regulatory effects of reduced PYK 
activity on the acetate synthesis pathway may also contribute to the lower acetate production.  
The measurements of several key metabolites and the acetate kinase activity indicate that low 
acetate formation in the iPYK mutant is primarily caused by reduced glycolytic flux and not by 
some regulatory effects on the acetate synthesis pathway due to reduced PYK activity.   
The dependence of PEP and glucose-6-phosphate (G-6-P) concentrations on IPTG 
induction level is shown in Figure 3.2. The concentration of PEP increases as the induction level 
decreases. The PEP concentration is dramatically higher in iPYK mutant cultivated in the 
absence of IPTG than that of the wild-type as was the case for the pyk mutant (Fry et al., 2000).  
One important consequence of higher PEP concentration for the iPYK mutant than the wild type 
is that the PYK flux may not have reduced to the same extent as the PYK activity. Another 
important consequence of high PEP concentration is its potential effect on glucose uptake rate. 
Since PEP is an inhibitor of phosphofructose kinase (PFK) in bacteria (Blangy et al., 1968; 
Doelle et al., 1982; Evans and Hudson, 1979; Hansen et al., 2002), it is conceivable that a high 
PEP pool will inhibit PFK. PFK catalyzes fructose-6-Phosphate to form fructose-1, 6-
biphosphate (FBP), thus the inhibition of PFK may result in high intracellular G-6-P 
concentrations, and consequently lower glucose uptake by the PTS system. Figure 3.2 shows that 
indeed G-6-P was significantly higher in the iPYK mutant induced with low levels of IPTG. For 
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the iPYK mutant in the absence of IPTG, the concentrations of PEP and G-6-P are very high 
leading to a very low glucose uptake rate as is evident from the low growth rate in the absence of 
IPTG. Induction of pyk expression with 0.05 mM IPTG, also led to higher concentrations of PEP 
and G-6-P, but the increase was much less pronounced than when there was no IPTG.  In the 
case of induction with 0.05 mM IPTG, good growth rate, high cell yield, and low acetate 
production were achieved.   
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Figure 3.2. Intracellular concentrations of PEP and G6P in batch cultures of iPYK mutant at several 
IPTG concentrations. 
The error bars represent the variations of three measurements. The black column represents the intracellular 
concentration of PEP and the white column represents intracellular G6P concentration in the exponential growth 
cells. The metabolites concentrations of wild-type (WT 168) and inducible PYK mutant (iPYK) of B. subtilis with 
various induction levels were presented. 
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The nil acetate production in iPYK mutant may also result from some regulatory effect 
on the acetate synthesis pathway. To elucidate if such a regulatory effect exists, the acetate 
kinase activity was measured in both wild type and iPYK mutant in the absence of IPTG. The 
measured activities were 0.2 and 0.16 units/mg protein, respectively. Additionally, the 
intracellular concentration of fructose-1,6-biphosphate (FBP) was measured (Figure 3.3).  FBP is 
required for carbon catabolite activation of genes on the acetate synthesis pathway (Presecan-
Siedel et al., 1999). The differences in the acetate kinase activities or the changes in FBP 
concentrations between the wild type and iPYK mutant are not significant enough to cause 
several fold reduction in acetate production. Thus, it is highly likely that the decrease in 
glycolysis flux is the key factor contributing to the decreased acetate formation. In addition, the 
intracellular of pyrvate is closely related to the induction level of pyruvate kinase, and figure 3.3 
showed that pyruvate, a precursor for lactate and acetate, was very low when the induction level 
is low. The significant decrease in formation of other acidic products (lactate and pyruvate, Table 
2) should also be caused by the lower glycolysis flux of the iPYK mutant. 
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Figure 3.3. Intracellular concentrations of Pyruvate and FBP in batch cultures of iPYK mutant at 
several IPTG concentrations. 
 
The error bars represent the variations of three measurements. The intracellular concentrations of fructose-1,6-
biphosphate (FBP) and pyruvate of iPYK mutant at various induction levels represented by IPTG concentration 
were presented in the same figure with wild-type (WT 168) for comparison. 
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3.2.4 Metabolic Flux Analysis. 
To calculate metabolic fluxes, a set of continuous cultures were carried out. The 
continuous culture data at dilution rate of 0.3 hr-1 were used to calculate the metabolic fluxes. 
Data for cell mass, glucose consumption, CO2 and acids were collected after the cultures reached 
steady state at dilution rate of 0.3 hr-1, as shown in Table 3. A detailed stoichiometric approach 
was used to calculate the carbon flux through the central carbon metabolic pathways (Goel et al., 
1995; Zhu et al., 2003). All metabolic intermediates are assumed to be at the pseudo-steady-state 
(no accumulation of metabolic pools).  
Infinite feasible solutions exist due to the degeneracy of problem. Using the MILP 
method or the convex analysis method (Zhu et al., 2003), extreme points of solution space at 
different culture conditions were found. Glucose consumption rate and acid formation rates were 
used in the calculation. 
At different IPTG levels, two extreme solutions were obtained.  The actual fluxes will be 
between these two values. A sample set of the metabolic fluxes of wild-type and iPYK mutant at 
three levels of induction is placed in Table 4.  The PYK fluxes of iPYK mutant at 0.05 mM 
IPTG are quite lower than the iPYK mutant at higher level of induction (0.2 and 1.0 mM IPTG) 
and wild-type.  This lower level of PYK flux for the iPYK mutant with 0.05 mM IPTG 
corresponds to lower pyruvate kinase and acetate production than the iPYK mutant at higher 
level of IPTG and the wild type. 
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 Table 3. Continuous cultures of wild-type and iPYK mutant at different levels of IPTG in minimal medium 
supplemented with 5 g/L glucose at dilution rate of 0.3 hr-1
 
  Wild type iPYK mutant 
IPTG 0 0.05 0.2 1
OD 2.23 2.64 2.43 2.27
Glucose consumed 2.65 2.36 2.75 2.88
Acetate 0.90 0.35 0.69 0.87
Pyruvate 0.12 0.04 0.22 0.29
Biomass yield* 0.37 0.49 0.39 0.34
Acids yield* 0.38 0.17 0.33 0.40
CO2 yield* 0.28 0.41 0.30 0.33
 
* Biomass yield is defined as the carbon content in the cell mass divided by the carbon in consumed glucose. Acids 
yield is defined as the carbon content in acids (both acetate and organic acids) divided by the carbon in consumed 
glucose. CO2 yield is defined as the carbon content in CO2 divided by the carbon in consumed glucose. 
 
 
 
Table 4. PYK fluxes of wild-type and inducible pyk mutant with different levels of induction  
 
  WT iPYK Mutant 
IPTG (mM) 0 0 0.05 0.2 1 
PYK fluxes 
(mmol/(g.hr)) 3.39-4.09  2.28-2.69 3.29-3.28 3.84-4.47 
 
The data for the flux analysis was obtained from the continuous cultures for both wide-type (WT) and inducible 
PYK (iPYK) mutant at dilution rate of 0.3 hr-1. The metabolic flux was calculated using the metabolic flux analysis 
software Metabologica (Zhu et al., 2003). 
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3.2.5 Inducible Phosphofructokinase (iPFK) Mutant of B. subtilis. 
 Our study with iPYK mutant of B. subtilis demonstrates that the PYK expression is 
closely related to glucose uptake, cell growth and acetate production. The PYK mutation reduces 
glucose uptake rate and glycolysis flux through a regulatory effect upon glycolysis pathway 
(Figure 3.4). Reduced PYK expression resulted in elevated intracellular PEP which inhibited the 
upstream enzyme PFK, and the inhibition of PFK resulted in the accumulation of G-6-P. G-6-P 
was reported to speed up the degradation of mRNA of ptsG (Morita et al., 2003) therefore reduce 
glucose uptake rate. Based on this hypothesis, the glucose uptake can be manipulated directly by 
modifying the expression level of PFK. Therefore, an inducible PFK mutant was constructed and 
its effect on glucose consumption, cell growth and acetate formation was investigated. 
 
  
 
Figure 3.4. Regulatory effects of PYK mutation on glucose uptake and glycolysis flux. 
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 iPFK mutant was grown in glucose(8g/L) minimal medium with various IPTG supply.  
Figure 3.5 shows PFK activity  at each induction level and PYK activities for uninduced and 
fully induced cultures. Activity of PFK is closely related to IPTG concentration in the iPFK 
mutant, following a similar pattern as that of PYK activity to IPTG concentration in the iPYK 
mutant. When there is no IPTG, the iPFK mutant still has 60% activity of PYK compared to 
wild-type. It was surprising that PFK and PYK expression responded to IPTG differently as both 
genes are in the same operon. These results indicate that the coordination of expression of pfk 
and pyk is disrupted by replacing the wild-type promoter with inducible promoter Pspac (Andersen 
et al., 2001). The low concentration of PEP in iPFK mutant with different induction levels also 
supported that PYK was expressed in considerate amount at the absence of IPTG (Figure 3.6).   
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Figure 3.5. Specific activities of phosphofructokinase (PFK) and pyruvate kinase (PYK) in iPFK 
mutant 
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Figure 3.6. The concentrations of intracellular metabolites in iPFK mutant at various induction 
levels.  
The intracellular metabolites were measured for exponential growth cells. G-6-P: Glucose-6-phosphate; PEP: 
Phosphoenolpyruvate; FBP: Fructose-1,6-biphosphate 
 
 The cell growth, glucose consumption and acetate production rates of iPFK mutant at 
various induction levels of PFK are shown in Figure 3.7. These results demonstrate  that cell 
growth, glucose consumption, and acetate production rates are closely related to the expression 
level of PFK. Therefore, we can control glucose uptake rate by manipulating either PFK or PYK 
expression in B. subtilis. From the comparison of iPFK and iPYK mutants, we also found that it 
is G-6-P that determines the glucose uptake and cell growth rates. Though PEP may also have 
some regulatory effect on glucose transport, its effect is minor as compared to G-6-P. 
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Figure 3.7. Batch cultures of iPFK mutant in minimal medium with 8 g/L glucose and various IPTG 
concentrations.  
 (A) Cell growth, (B) glucose consumption, (C) acetate production. 
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4.0  RECOMBIANT PROTEIN PRUDUCTION  
4.1 INTRODUCTION  
 Previous work has demonstrated that acetate production was eliminated after the pyk 
mutation in B. subtilis. The acetate production was frequently reported to have detrimental effect 
on recombinant protein production (George et al., 1992; Jensen and Carlsen, 1990; Hahm et al., 
1994) and strategies led to reduced acetate formation usually resulted in improved recombinant 
protein production (Aristidou et al., 1995; Jaoon et al., 2003; March et al., 2002). Therefore, we 
investigated the impact of pyk mutation on recombinant protein production. GFP+ was selected 
as a model protein and constitutively expressed in both wild-type strain and inducible pyk 
mutant. 
4.2 RESULTS  
4.2.1 Comparison of GFP+ Production in Wild-type and Inducible PYK Mutant Grown 
in Glucose Minimal Medium 
To investigate how the change of PYK flux affects recombinant protein production in B. 
subtilis, we introduced a plasmid bearing gfp+ gene into both the inducible PYK mutant and the 
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wild-type B. subtilis, resulting in two GFP+ production strains,  i.e., MTpGFP+ and WTpGFP+. 
The expression of GFP+ in these strains was under the control of the constitutive B. subtilis vegII 
promoter of pRB374. The production of GFP+ from each strain in batch cultures in minimal 
medium with 5 g/L glucose was compared. As shown in Figure 4.1, GFP+ was constitutively 
expressed during the cultivation in a partially growth related fashion. The growth rate of 
uninduced MTpGFP+ (0.15 hr-1) was about 30% of the WTpGFP+ (0.51 hr-1), but its total GFP+ 
production in the culture of MTpGFP+ is 3-fold higher than that of the wild-type culture 
(WTpGFP+). On a per cell basis, MTpGFP+ also produced 100% higher GFP+ as represented by 
the fluorescence intensity (Table 5). Additionally, uninduced WTpGFP+ produced about 0.72 
g/L acetate while MTpGFP+ produced about 80% less acetate. As expected, the inclusion of 0.05 
mM IPTG in the cultures of MTpGFP+ did not lead to significant increase in acetate production, 
but the GFP+ production was substantially lower than the uninduced culture. 
Considering the specific GFP+ production rate (GFP+/(time·cell)) as it is represented as 
RFU/OD/hr in Table 5, it is 15% higher in MTpGFP+ cultures both uninduced or induced with 
0.05mM IPTG than that in the WTpGFP+ culture. This analysis shows that despite significantly 
lower growth rate, the specific production rate of the mutant is similar to the wild-type. 
Assuming the turnaround time for a batch culture is 10 hour; the average production rate is 10 
RFU/hour for WTpGFP+ and 17.8 RFU/hour for MTpGFP+. Thus, in terms of both volumetric 
production rate and product concentration, the uninduced MTpGFP+ is superior for protein 
production. Moreover, when high cell density fed-batch cultures are considered, the mutant 
performance may even be much more pronounced given that its low acetate production rate 
would limit total acetate production and hence minimize the inhibitory effect of acetate at high 
concentrations. Furthermore, it is likely that under conditions that very high levels of protein 
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expressions are examined the mutant could devote more biosynthetic resources to the 
recombinant protein production due to lower levels of acetate production. 
The high GFP+ production in MTpGFP+ may be due to the following factors: (1) slower 
growth rate and longer culture time, leading to longer production time; (2) change of amino acid 
pools after down-regulating pyk as the pyk mutation leads to the redistribution of carbon and 
energy among central carbon metabolism pathways. (3) slower degradation of GFP+ by 
proteases considering the lower ATP flux/higher ATP yield in the pyk mutant; (4) lower acetate 
production, as it is widely accepted as a factor that limits recombinant protein production; (5) 
more stable plasmid in the iPYK mutant; (6) elevated intermediate metabolites (PEP and G6P) 
which may exert regulatory effect on GFP+ expression. Each factor will be elaborated in the 
following sections. 
 
 
Table 5. Summary of batch cultures of wild-type (WTpGFP+) and iPYK mutant (MTpGFP+) bearing pGFP+ 
in minimal medium with 5 g/L glucose 
 
 
Maximal 
OD660nm 
Acetate 
(g/L) 
RFU/OD µ 
hr-1
RFU/OD/hr 
WTpGFP 3.76 0.72 59 0.51 7.2 
MTpGFP+ with 
0.05mM IPTG 3.85 0.31 78 0.15 8.1 
MTpGFP+ 4.25 0.15 116 0.37 8.2 
RFU: Relative Fluorescence Unit. 
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Figure 4.1. Cell growth and GFP+ production in batch cultures of wild-type strain (WTpGFP+) and 
inducible pyk mutant (MTpGFP+) in glucose (5 g/L) minimal medium. 
MTpGFP+/0.05mM IPTG: 0.05mM IPTG was added in the medium at the beginning of MTpGFP+ culture. 
 
 58 
4.2.2 GFP+ Stability 
The difference of GFP+ production in WTpGFP+ and MTpGFP+ may result from both 
the synthesis side and/or degradation side. B. subtilis usually produces a lot of proteases which 
limit the yield of heterologous proteins. Many of these proteases are ATP-dependent (Nakano, et 
al., 2002; Wehrl et al., 2000). The iPYK mutant shows much higher ATP yield from the 
metabolic flux analysis, and the low energy level is favorable for the recombinant protein 
production since protein turnover via ATP-stimulated proteases is suppressed. To test if protein 
degradation is indeed a factor, we monitored the stability of GFP+ in the medium. 10 mL late-
exponential phase cultures was filtered with 0.45 µm disposable filters, and the filtrate was kept 
at room temperature for a couple of days. No significant change of fluorescence in the cell-free 
medium was observed, indicating GFP+ is very stable and has strong resistance to protease-
mediated degradation, which is consistent with other reports (Hoskins and Wickner, 2006; Roth 
and Ward, 1983). Therefore, higher recombinant protein production in MTpGFP+ more likely 
results from synthesis side factors. 
4.2.3 Gene Expression Levels in WTpGFP+ and MTpGFP+ 
The accumulation of acetate is widely accepted to have inhibitory effect on recombinant 
protein production (Jensen and Carlsen, 1990; Hahm et al., 1994; Huang et al., 2004). However, 
the mechanism of the detrimental effect of acetate on cell growth and recombinant protein 
production remains unclear. Acetate may potentially affect transcription or translation processes 
or both of them. To better understanding this process, the gene expression levels of WTpGFP+ 
and MTpGFP+ was measured using quantitative RT-PCR. Figure 4.2 shows the relative mRNA 
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levels of gfp+ in cells harvested in the exponential growth phase. The image analysis of band 
intensity shows that the mRNA levels for WTpGFP+ and MTpGFP+ are almost same. Therefore, 
the higher GFP+ production, which corresponds to lower acetate production, is probably due to 
the higher efficiency of translation based on our results in this study. Recent evidence showed 
that high glucose concentration which corresponds to acetate-forming conditions also activates 
the methyl glycoxalate pathway in bacteria (Weber et al., 2005). The methyl glyoxalate pathway, 
which converts dihydroxyacetone phosphate (DHAP) to pyruvate via methylglyoxal and D-
lactate, may short-cut the glycolysis pathway and lead to limited energy (ATP) supply for 
biosynthesis. In addition, methyl glyoxalate itself is a highly toxic compound and may adversely 
react with deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins (Lo et al., 1994; 
Papoulis et al., 1995). 
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Figure 4.2. mRNA levels of WTpGFP+ and MTpGFP+. 
From left to right: lane 1, Marker; lane 2&3, WTpGFP+; lane 4&5, MTpGFP+; lane 6&7, 2× WTpGFP+; lane 8&9, 
2× MTpGFP+; lane 10, Control. 
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4.2.4 Effect of Acetate in the Medium on GFP+ Production  
The inhibitory effect of acetate on cell growth and recombinant protein production in E. 
coli usually occurred in the range of 3 ~5 g/L (Aristidou et al., 1995; Luli and Strohl, 1990). For 
some species and proteins, the inhibitory concentration of acetate could be even lower.  Huang et 
al. (2004) reported that addition of 1g/L acetate seriously inhibited cell growth and that 
concentrations as low as 0.1 g/L acetate in the medium could be sufficient to significantly repress 
amylase production in a recombinant B. subtilis strain. To investigate if the accumulation of 
acetate in the medium limited the protein production, WTpGFP+ was cultivated in glucose 
minimal medium supplied with varying amount of sodium acetate. The results show that the 
addition of acetate in the medium up to 2 g/L has no remarkable effect on both cell growth and 
recombinant protein production (Figure 4.3). In previous batch cultures, acetate never 
accumulated to more than 1 g/L in the medium, therefore, the lower GFP+ production in our 
wild-type strain WTpGFP+ was not due to a higher concentration of accumulated acetate in the 
medium. Instead, acetate production rate may be the key factor affecting protein synthesis which 
seems to be very sensitive to the redirection carbon flow from acetate production to protein 
synthesis (March et al., 2002). 
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Figure 4.3. Effects of acetate in the medium on cell growth and protein production of WTpGFP+. 
The glucose (30 mM) minimal medium was supplemented with 0.0, 0.5, 1.0, and 2.0 g/L sodium acetate. 
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4.2.5 Metabolic Modeling of Potential Recombinant Protein Production 
Previous results implied that recombinant protein synthesis seems to be very sensitive to 
the acetate production rate. In MTpGFP+, less acetate was produced which could permit a 
greater surplus of metabolic resources to be directed toward protein synthesis. To explore this 
possibility, metabolic flux calculations were performed. A stoichiometric model of the 
central carbon metabolism of B. sbutilis was built using the software Metabologica (Zhu et al., 
2003). Glucose was the sole source of carbon and energy, and carbon was allowed to exit the 
network through CO2 evolution, byproduct (acetate, lactate, pyruvate, succinate) formation, and 
biomass synthesis. The model assumes that all metabolic intermediates are at the pseudo-steady-
state (no accumulation of metabolic pools). Additionally, constraints such as net NADPH 
formation for reductive biosynthesis and minimum ATP requirements are included in the model 
formulation. These constraints limit the metabolic trafficking alternatives as well as insure that a 
particular solution is physiologically feasible. Finally, a reaction for GFP+ synthesis was built to 
determine how sensitive GFP+ production is to the change of flux to acidic byproducts (Figure 
4.4). The amino acid composition of GFP+ was determined from the translation table presented 
at open source NCBI (Accession No. CAH64882), and the overall stoichiometry of metabolic 
precursors for GFP+ synthesis was taken as that presented at Table 6. Information about 
metabolite and energy requirements for the production of each amino acid and peptide bond was 
obtained from the literature (Vijayasankaran et al., 2005). To find all feasible solutions, glucose 
uptake and CO2 evolution rates, as well as by-product production rates were not constrained in 
the model. Then the software Metabologica was used to solve the model for all metabolic 
trafficking alternatives meeting the specific constraints and assuming a dilution rate of 0.3 hr-1.  
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 Table 6. Metabolic synthesis requirement for the production of GFP+ 
R5P, Ribose-5-phosphate; E4P, Erythrose-4-phosphate; PEP, Phosphoenol pyruvate; 3GP, 3-
phosphoglycerate; AcCoA, Acetyl coenzyme A; α-KG, α-ketoglutarate; OAA, Oxaloacetate. 
 
                      
Amino Acid Moles R5P E4P PEP 3GP Pyruvate AcCoA α-KG OAA ATP NADH NADPH
Alanine 9     9      9 
Arginine 7       7  49 -7 28 
Asparagine 13        13 39  13 
Aspartate 18        18   18 
Cysteine 2    2     8 -2 10 
Glutamate 16       16    16 
Glutamine 7       7  7  7 
Glycerine 22    22      -22 22 
Histidine 10 10        60 -30 10 
Isoleucine 12     12   12 24  60 
Leucine 20     40 20    -20 40 
Lysine 20     20   20 40  80 
Methionine 5        5 35  40 
Phenylalanine 11  11 22      11  22 
Proline 10       10  10  30 
Serine 11    11      -10 10 
Threonine 17        17 34  51 
Tryptophan 1 1 1 1      5 -2 3 
Tyrosine 11  11 22      11 -11 22 
Valine 16     32      32 
peptide bond          952   
GFP+ 238 11 23 45 35 113 20 40 85 1285 -104 523 
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Figure 4.4. The metabolic reaction network of B. subtilis used for the modeling of potential 
recombinant protein synthesis 
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Twenty-eight different feasible solutions were found to exist. The GFP+ flux and 
corresponding acids flux (mmol/(g cell·hr)) for those solutions were plotted in the phase plane 
(Figure 4.5). Any point inside the bounded region is a feasible solution. Overall, the modeling 
determined what the maximum GFP+ production rate could be at each acid formation rate. 
Figure 4.5A demonstrates that the maximum GFP+ production rate is limited at high acetate 
formation rate. Perhaps the more interesting finding is the relationship between GFP+ flux and 
PYK flux. GFP+ production was limited at both the high and low end of PYK flux (Figure 
4.5B), however, our experimental data showed that GFP+ production was higher at low levels of 
PYK activity. This discrepancy may be resulted from the assumptions we have made during the 
modeling. In this model, we have not included the reaction between phosphoenolpyruvate (PEP) 
and Oxaloacetate (OAA). When PYK activity is low, the phosphoenolpyruvate carboxykinase 
(PCK) may operate at the direction from PEP to OAA (Zamboni et al., 2004; Pan et al., 2006). 
When PCK is operative, our modeling results showed that the maximum GFP+ production 
capacity was attained at the low end of PYK flux (Figure 4.5C). The correlation of GFP+ flux 
versus acid flux with PCK included is similar to Figure 4.5A. 
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Figure 4.5. Solution spaces for GFP+ production. 
A and B: the phosphoenolpyruvate carboxykinase (PCK) was not included; C: PCK catalyzed reaction was included.   
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4.2.6 GFP+ Production in Semi-Rich Medium 
Given that the specific GFP+ production rate is similar between wild type and mutant 
despite the significant differences in growth rate, an interesting question is how the production 
rates will be affected in cultures supplemented with biosynthetic precursors. The recombinant 
GFP+ production of WTpGFP+ and uninduced MTpGFP+ cultures in glucose (5 g/L) minimal 
medium with 2 g/L LB was compared. LB is composed of 20% yeast extract, 40% tryptone and 
40% sodium chloride. The amino acid components in LB should partially provide precursors for 
protein synthesis therefore lessen the burden of amino acids that need to be supply from glucose 
catabolism. As shown in Figure 4.6, the addition of LB increased both cell growth and GFP+ 
production rates, however, both WTpGFP+ and MTpGFP+ produced similar amount of protein 
to their counterparts in glucose minimal medium (Figure 4.1) at the end of growth period. These 
results may suggest that both WTpGFP+ and uninduced MTpGFP cultured with glucose as the 
only carbon source (Figure 4.1) are translating the gfp+ transcripts at their maximum capacity 
and that it is the availability of biosynthetic precursors not the growth rate that determine the 
specific production rate of GFP+.   
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Figure 4.6. Cell growth and GFP+ production in batch cultures of WTpGFP+ and MTpGFP+ in 
semi-rich medium(C medium with 5 g/L glucose and 2 g/L LB). 
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4.2.7 Effect of Carbon Sources on Recombinant Protein Production in Batch Cultures of 
WTpGFP+  
Pyruvate is supplied from both phosphoenolpyruvate (PEP)-sugar phosphotransferase 
system (PTS) and PYK when a PTS sugar such as glucose is employed as a carbon source. 
Besides PYK mutation, pyruvate supply can also be reduced by inactivating the PTS (Chen et al., 
1997) or by using a non-PTS substrate as carbon source, which should potentially reduce acetate 
formation and improve recombinant protein production. To test this hypothesis, the GFP+ 
expression of WTpGFP+ cultivated with either glucose or glycerol as the sole carbon source was 
compared. WTpGFP+ was grown in minimal medium supplemented with 5g/L glucose or 
glycerol, and their respective cell growth rate, acetate accumulation and recombinant protein 
production were compared. As shown in Figure 4.7, the culture with glycerol grew as fast as the 
culture with glucose. In addition, the glycerol culture obtained a 35% higher maximum cell 
density and 60% less acetate. Moreover, the expression of recombinant protein GFP+ is 60% 
higher in the culture with glycerol as compared to that of the culture with glucose. The glycerol 
culture also showed higher GFP+ production per cell and higher productivity. The high GFP+ 
production in glycerol minimal medium may be due to lower acetate formation. In addition, the 
cells (E. coli) grown in glycerol medium may have greater tolerance to acetate than those grown 
in glucose (Lasko et al., 2000). The differences amongst carbon sources are even more 
prominent at high concentrations. Cultures of WTpGFP+ in minimal medium with 20 g/L 
glycerol produced 150% more GFP+ as compare to cultures with 20 g/L glucose (data not 
shown). 
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Figure 4.7. Cell growth, acetate formation and GFP+ production of WT168pGFP+ in C medium with 
5g/L glucose (Triangle) or glycerol (Square). 
(A) Cell density (solid symbols) and acetate (open symbols), (B) total fluorescence (solid symbols) and medium 
fluorescence (open symbols), (C) fluorescence per optical density. 
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5.0  FOLIC ACID PRODUCTION 
5.1 INTRODUCTION 
 The bulk of commercially sold folic acid is currently produced via chemical synthesis 
due to the low yield of folic acid provided by current microbes. Several reasons, however, have 
prompted new exploration into using microbes for the commercial production of folic acid. First, 
the glutamated and reduced form of the natural vitamin produced by bacteria produce is what the 
digestive system designed to process. Secondly, a single-step fermentation route is more 
environmentally benign than a multi-stage chemical process. Thirdly, the yield of folic acid 
production could be dramatically improved by metabolic engineering the production strain. One 
of the potential production strains is B. subtilis. In addition to its “generally regarded as safe” 
status by FDA, B. subtilis has been successfully used to produce these products metabolically 
related to folic acid such as D-ribose (De Wulf and Vandamme, 1997) and riboflavin (Perkins et 
al., 1999). Two outcomes of PYK mutation in B. subtilis, low acetate and high PEP and G-6-P 
concentration, may potentially improve the productivity of folic acid. While low acetate 
formation may help reach high cell density, high PEP and G-6-P may improve folic acid 
synthesis by providing precursors. We hypothesis the PYK expression level will significantly 
affect folic acid production. Both metabolic flux prediction and experimental measurement will 
be conducted to test this hypothesis. 
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5.2 RESULTS 
5.2.1 Network Model and Flux Predictions  
A stoichiometric model of the central carbon metabolism with a lumped reaction leading 
to folic acid was built using the software Metabologica (Zhu et al., 2003).  A reference specific 
growth rate of 0.4 h-1 was used to generate flux units (e.g. mmol g cell-1 h-1). The overall 
stoichiometry inputted into Metabologica for the lumped reaction that leads to folic acid (FA) 
production is 
2PEP + E4P + 2 3-PG + KG + 11ATP + R5P + 4NADPH ? FA + PYR + CO2   
where PEP (phosphoenolpyruvate), E4P (erythrose-4-phosphate), 3-PG (3-phosphoglyceric 
acid), KG (oxoglutarate), R5P (ribose-5-phosphate), and PYR (pyruvate) are both FA precursors 
and intermediate metabolites present in central carbon metabolism. We found that 32 different 
feasible solutions exist for the growth of folic-acid producing B. subtilis in glucose minimal 
medium.  The use of phase plane-like graphical displays provides a means for exploring the 
effect of pyk mutation (Figure 5.1), where PYK-catalyzed flux is the X dimension and folic acid 
flux is the Y dimension. Any point inside the bounded region is a feasible solution.  The 
maximum folic acid synthesis rate increases linearly as the PYK catalyzed flux decreases to zero.  
The geometry of the phase plane boundary also suggests that as PYK flux decreases to zero, 
solutions that yield high folic acid productivity still exist. 
These solutions indicate that highly attenuated PYK flux may be associated with a 
metabolically feasible and high folic acid-yielding scenario. The concentration of the folic acid 
precursors, PEP and 3-PG, may increase due to a downstream blockage in consumption, and this 
increase could stimulate folic acid synthesis.  Accordingly, the modeling results and envisioned 
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mass action consequences suggest that a strategy based on decreasing PYK flux may work in B. 
subtilis (Zhu et al., 2005). 
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Figure 5.1. Phase planes for folic acid production. 
Folic acid formation rate vs. PYK flux (Zhu et al., 2005).  
 
 
 
5.2.2 Effect of pyk Expression on Productivity of Folic Acid in B. subtilis. 
 Prior results showed that the pyk mutant of B. subtilis has dramatically elevated PEP and 
G6P pool, both of which are precursors for folic acid biosynthesis. Our first experiment is to 
explore how the expression of pyk can change the folic acid yield as well as to investigate 
whether a high yielding (amount per cell) and productive strain (amount per time) could be 
developed.  
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Figure 5.2 shows the folic acid yield and doubling time exhibited by iPYK mutant of B. 
subtilis when different levels of IPTG are provided in glucose minimal medium. The yield and 
doubling time characteristics of iPYK mutant are also contrasted to those exhibited by B. subtilis 
168 (trpC2). When 0.2 mM IPTG is present, the growth rate of iPYK mutant is essentially equal 
to that of B. subtilis 168 (trpC2), whereas the growth of iPYK mutant is very slow when no 
IPTG is added.  Both this result and enzyme activity measurements indicate that significant 
control via IPTG induction exists over pyk expression in iPYK mutant.   
The advantage of inducible control of pyk is evident in the case when the IPTG 
concentration was set to 0.02 mM. The several-fold enhancement in folic acid yield of iPYK 
mutant as compared to B. subtilis 168 (trpC2) is similar to that exhibited by the pyk knockout.  
However, the doubling time of iPYK mutant with 0.02 mM IPTG is several-fold smaller than the 
knockout mutant.  Consequently, when pyk induction is controlled, a three-fold increase in folic 
acid yield can be obtained while sustaining 60% of the parent strain’s growth rate. Reasonable 
growth rate, in turn, translates into increased bioprocess productivity.  
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Figure 5.2. How folic acid yield (white bar) and doubling time (gray bar) depend on IPTG 
concentration in strain iPYK mutant of B. subtilis. 
The parent strain’s (B. subtilis 168) folic acid yield and doubling time are included for comparison (Zhu 
et al., 2005).  
 
 
5.2.3 Folic Acid Yield for Other B. subtilis Mutants 
Para-aminobenzoic acid (PABA) pathway may be rate limiting for folic acid synthesis in B. 
subtilis, based on the experimental results that addition of PABA in the medium dramatically 
increased folic acid production (Miyata et al., 1999). Metabolic engineering approaches to 
enhance the flux to PAPA pathway may result in improved folic acid production. The folic acid 
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yields and growth rates exhibited by 1A96 (pheA1, trpC2), BSZT0410 (trpC2, aroHover), 
BSZT0412 (trpC2, aroHover, tktAover), and BSZT0408 (trpC2, mtrB::cm) were measured in 
glucose minimal medium. The yields and growth rates are compared to each other and those of 
B. subtilis 168 (trpC2) in Table 7 (Zhu et al., 2005).  The cell mass concentration at time of the 
sampling and the yield on the basis of total volume of cells and spent medium are also listed in 
Table 7. Amplifying aroH (BSZT0410) and disrupting mtrB (BSZT0408) both increase the folic 
acid yield by about 80%.  Blocking phenylalanine production (1A96) increases the folic acid 
yield by about 100%.  In contrast, amplifying the tktA gene (BSZT0412) reduced the folic acid 
yield by 46% as compared to the parent strain (BSZT0410). 
5.2.4 Combinations of Mutation Strategies 
The different mutation strategies that introduced inducible expression of pyk, aroH 
amplification, and mtrB disruption were combined to explore the synergistic effects.  The folic 
acid yields of BSTZ0419 (trpC2, mtrB::cm, pykind), BSTZ0425 (trpC2, aroH, pykind), and 
BSTZ0437 (trpC2, aroHover mtrB::cm, pykind) are listed in Table 7 along with doubling times, cell 
yields, and volumetric yields. The combination of the three mutations in BSTZ0437 resulted in 
an 8-fold increased yield of folic acid as compared to B. subtilis 168.  Moreover, the growth rate 
and carbon yield of BSTZ0437 are both about 70% of the starting strain 168 when 0.05 mM 
IPTG is added to induce pyk. 
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 Table 7. Folic acid yields of wild-type & engineered B. subtilis in glucose minimal medium (5g/l) 
 
Strain 
Name 
Description Doubling 
Time 
(hour) 
Folic Acid 
Mass Yield 
(mg /g cell) 
Dry Cell Mass 
Concentration 
(g/L) 
Volumetric Yield 
Folic 
(mg/L) 
168 trp2C 1.08 ± 0.08 14.7 ± 0.7 1.95 ± 0.05 28.7 
1A96 trp2C, pheA 1.08 ± 0.08 30.2 ± 2.0 1.98 ± 0.04 59.8 
BSZT0410 trpC2, aroHover 1.15 ± 0.08 26.8 ± 1.3 1.85 ± 0.05 49.6 
BSZT0412 trpC2, aroHover, tktAover 1.40 ± 0.1 14.3 ± 0.7 1.60 ± 0.05 22.9 
BSZT0408 trpC2, mtrB::erm 1.20 ± 0.1 26.3 ± 1.5 1.78 ± 0.05 46.8 
BSZT0419 trpC2, mtrB::cm, pykind 1.50 ± 0.1* 56.0 ± 4.0 1.75 ± 0.05 98 
BSZT0425 trpC2, aroH, pykind 1.25 ± 0.1* 60.0 ± 4.0 1.90 ± 0.06 114 
BSZT0437 trpC2, aroHover  
mtrB::cm, pykind
1.60 ± 0.2* 113 ± 11.0 1.45 ± 0.05 163 
* 0.05 mM IPTG was added in the culture at time 0 (Zhu et al., 2005). 
 
 79 
6.0  BACILLUS THURINGIENSIS  
6.1 INTRODUCTION 
Bacillus thuringiensis (Bt) is a gram-positive and spore-forming microorganism. It is 
widely used in agriculture and forests as an efficient pest control method because it can produce 
crystal proteins (endotoxins) in the cells during sporulation, which are toxic to many insect 
species (Schnepf et al., 1998). The low toxicity of Bt toxin to humans makes it desirable to 
improve the production of these alternatives to synthetic organic pesticides.  
Many studies have shown that improving cell yield, toxin production, and sporulation is 
dependent on glucose concentration (Kuppusamy and Balaraman, 1991; Liu et al., 1994). Recent 
evidence shows that some of the toxin genes are repressed in the presence of glucose by 
catabolic repression (Banerjee-Bhatmagar, 1998) and a mutation in the catabolic repression site 
of HPr released the cry4A expression from the repression of glucose and resulted in higher 
transcripts (Khan and Banerjee-Bhatnagar, 2002), which implies that the central metabolic 
process plays an important role in the regulation of crystal toxin synthesis in Bt. Another study 
showed that the growth rate had a significant effect on the distribution of the consumed glucose 
(Mignone and Avignone-Rossa, 1996). The fraction of glucose consumed for biomass synthesis 
decreases with the growth rate, while the glucose flux through the TCA cycle reduces after a 
threshold value. The decrease of glucose flux through the TCA cycle is compensated by an 
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increase in the fraction of glucose being converted into acids. These results indicate that there is 
a mismatch between glycolysis and TCA cycle capacity, depending on the growth rate.  
Although extensive work has been done to reduce acetate accumulation in E. coli and B. 
subtilis culture systems, the extension of these findings to B. thuringiensis cultures has received 
little attention. Based on our knowledge of B. subtilis, we hypothesized that the feeding of citrate 
would reduce acetate formation and improve the production of the toxin protein.  In batch 
cultures, the inclusion of citrate in the growth medium was not as effective during the early 
exponential phase when the growth rate is high due to the presence of LB and low concentration 
of inhibitory by-products. However, production of acetate was significantly reduced and biomass 
yield substantially increased in the presence of citrate in continuous cultures operating at 
intermediate growth rates. Based on these results, it is conceivable that citrate will prove 
effective in reducing acid formation in fed-batch cultures where the growth rate is maintained 
below the maximum growth rate. Analysis of metabolic fluxes in continuous culture revealed 
that the glycolytic flux was significantly lower in the presence of citrate, and similar to B. subtilis 
cultures, pyruvate kinase flux was substantially attenuated. Thus, mutation of the pyruvate kinase 
gene in Bt may be a worthwhile metabolic engineering strategy to be tested for reducing acetate 
production and improve biomass yield. 
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6.2  RESULTS 
6.2.1 Nutrition Requirements for Bacillus thuringiensis (Bt) 
The Bt strain used in this study was unable to grow in glucose minimal medium (BGM + 
glucose). Additionally, supplementation of glucose minimal medium with glutamate, aspartate, 
citrate, or EDTA did not support cell growth as previously reported for other Bt strains 
(Nickerson and Bulla., 1974a). Addition of LB or yeast extract to glucose minimal medium 
enables good growth of the Bt strain. Batch experiments in basic growth medium (BGM) 
supplemented with glucose and either LB or yeast extract (10g/L glucose and 10g/L LB or yeast 
extract) revealed that LB is better for sporulation and toxin production than the more commonly 
used yeast extract. As shown in Figure 6.1, spores and crystal inclusion bodies are more 
prevalent in cells cultured with LB in the medium than when yeast extract is used. This 
improvement could be due to the positive effect of NaCl on spore formation in LB (Ghribi et al., 
2005). Thus, in all our subsequent experiments, LB was added to the glucose minimal medium.    
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  A 
 
  B 
 
Figure 6.1. Morphology of Bt after 24 hour cultivation in BGM supplemented with 10g/L glucose and 
either 10g/L LB (A) or yeast extract (B). 
Note that both spores and toxin protein crystals appear as phase bright inclusions in cells.  A cell with two 
inclusions, as is the case for most cells in the LB culture, contains both a spore and a toxin crystal. 
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6.2.2 Effect of the Ratio of LB/Glucose in Batch Cultures 
The glucose minimal medium (BGM) with a glucose concentration of 10 g/l was 
supplemented with different amounts of LB. The results of these batch experiments are shown in 
Figure 6.2 and summarized in Table 8.  The maximum optical density (OD) increased as the LB 
concentration was raised from 1 to 7 g/L, but further increasing the LB concentration to 20 g/L 
did not increase the cell density.  Table 8 shows that glucose was fully utilized in cultures with 
LB concentrations of 5 g/l corresponding to an LB/glucose ratio of 1:2 or higher, but not in 
cultures with LB concentrations below 3 g/L. Moreover, higher levels of sporulation were 
reached at LB/glucose ratios between 5:10 and 10:10.  For LB/glucose ratios above 10:10, cell 
density did not increase and there was an adverse effect on sporulation. The carbon/nitrogen 
(C/N) ratio of mixtures of LB and glucose was calculated based on 10% nitrogen content in the 
yeast extract and tryptone components of the LB. Glucose/LB ratios between 10:5 and 10:10 
correspond to C/N ratios of 6.8 to 4.5. This observation is consistent with a report indicating that 
sporulation was either initiated or enhanced by reducing the nitrogen source in several Bt 
production media (Pearson and Ward, 1988). The best C:N ratio may be strain-dependent, but 
the highest relative crystal protein production was reported to occur with a C: N of 7:1 in Bt var. 
kurstaki HD-73 (Farrea et al., 1998). In summary, the results of Table 8 show that a LB/glucose 
ratio of 1:2 will be sufficient to achieve full glucose utilization and high sporulation efficiency.   
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Table 8. Effect of LB concentration on cell growth and sporulation in shake flask cultures with 10 g/L glucose  
 
Exp 
No 
LB 
(g/L) 
C:N Residue 
Glucose 
(g/L)  
Max OD 
(660nm) 
Spore Counts 
(24 hr) 
(× 108/mL) 
1 3 8.5 3.12 8.6 1.1 
2 5 6.8 0 14.2 6.5 
3 7 5.6 0 21.4 7.8 
4 10 4.5 0 23.5 7.9 
5 20 2.7 0 22.4 2.0 
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Figure 6.2. Cell growth and glucose utilization of Bt under different LB supplements in BGM with 
10g/L glucose. 
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6.2.3 Effect of Citrate on Growth and Acids Formation in Batch Cultures with High 
Initial Glucose Concentration 
The effect of citrate on growth and acid formation in batch cultures of Bt was 
investigated with an LB/glucose ratio of about 1:2. The medium was comprised of BGM, 10.8 
g/L glucose, 5g/L LB, and 1.8 g/L sodium citrate or no citrate. As shown in Figure 6.3, cultures 
with and without citrate grew at the same rate, produced similar amounts of acetate, and 
consumed about same amount of glucose. Acetate accumulated in the culture broth over the first 
few hours during the exponential growth phase followed by a decrease in cell growth rate and 
rapid consumption of acetate. Thus, citrate was not effective in either enhancing cell density or 
reducing acetate production in this batch growth experiment.  As shown in Figure 6.3B, citrate 
was not consumed in the first 3 hours when glucose concentration in the medium was still high 
and most of acetate was produced, indicating possible catabolite repression of citrate utilization 
by glucose (Warner et al., 2000; Meyer et al., 2001).  
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Figure 6.3. Effect of citrate on cell growth and acetate production in batch culture of Bt in BGM with 
5 g/L LB and glucose: 10.8 g/L; Citrate: 1.8 g/L. 
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6.2.4 Citrate Uptake in Bt at Different Initial Glucose Concentrations 
To investigate the catabolic effect of glucose concentration on citrate utilization, a set of 
experiments with various initial glucose concentrations were conducted in shake flask cultures.  
The culture medium contained 0.9 g/L citrate and 5 g/L LB. The cell growth, glucose 
consumption, citrate utilization, and acetate production are shown in Figure 6.4. For the culture 
with an initial glucose concentration of 10.8 g/L, citrate was not consumed initially until glucose 
concentration dropped below 5 g/L. Citrate consumption was also evident in the culture with an 
initial glucose concentration of 5.4 g/l at the early stage of growth. For the culture with initial 
glucose concentration of 1.8g/L, citrate was consumed from the beginning of growth phase and 
was quickly consumed in the first 2 hours. It is of interest to note the pattern of acetate 
concentration (Figure 6.4D). Acetate is only produced during early exponential growth. 
Moreover, results with initial glucose concentrations of 10.8 and 5.4 g/l reveal that acetate 
uptake becomes significant at about 6 and 3 hours of growth, respectively, corresponding to 
glucose concentration of about 3 g/l. Overall, results of Figure 6.4 indicate that citrate can be 
metabolized at glucose concentration below 5g/L and that acetate uptake becomes significant 
when glucose concentration drops below 3 g/l. 
The above experiments were conducted with fixed LB concentration, and the LB/Glucose 
ratio changed with various initial glucose concentrations. In another set of experiments where 
glucose/LB ratio was fixed at 2/1, the culture with 2 g/L initial glucose produced much less 
acetate as compared to cultures with 5.4 g/L and 10.8 g/L glucose (data not shown). The specific 
citrate uptake rates decline with increasing glucose concentration and its trend is similar to that 
of previous set of experiments. 
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Figure 6.4. Batch cultures of Bt in BGM with 5g/L LB and 0.9 g/L citrate and variable initial glucose 
concentrations. 
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6.2.5 Effect of Citrate on Growth and Acids Formation in Batch Cultures with Low 
Initial Glucose Concentration 
To investigate the effect of citrate on growth and acid formation in batch cultures of Bt, 
an initial glucose concentration of 3 g/l was used to ensure that citrate transport would not be 
inhibited.  The LB concentration of 1.5 g/l corresponding to LB/glucose ratio of ½, significantly 
lower than the amount used for experiments reported in Figure 6.4, was used in this experiment.  
As shown in Figure 6.5, cultures with and without citrate grew at same rates, produced similar 
peak concentrations of acetate, and consumed about same amount of glucose in the first three 
hours of growth period. The key difference between the two cultures appears to be that in 
cultures provided with citrate, acetate was produced during the initial growth period (as was the 
case in Figure 6.4), while acetate production continued throughout most of the growth period in 
the culture lacking citrate. We hypothesized that this difference indicates that citrate is effective 
at moderate growth rates and/or lower LB concentrations. To test this hypothesis, and to gain 
some insight into possible regulatory role of citrate, continuous cultures at several dilution rates 
(growth rates) were conducted.  
.  
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Figure 6.5. Effect of citrate on cell growth and acetate production in batch culture of Bt in BGM with 
1.5 g/L LB and glucose: 3 g/L; Citrate: 0.6 g/L. 
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6.2.6 Effect of Citrate in Continuous Cultures at Various Dilution Rates. 
Continuous culture experiments at various dilution rates from 0.1 to 0.4 hr-1 were 
performed to test the effect of citrate on cell and acetate production at different growth rates. 
Cells were grown in BGM (containing 3 g/l glucose) plus 1 g/L LB with and without citrate. As 
shown in Table 9, at dilution rate of 0.1 h-1, no acetate was detected in the presence or absence of 
citrate (runs 1 and 2). Glucose was completely utilized in both cultures.  
At higher dilution rates of 0.2 and 0.3 h-1 (runs 3-6), acetate was present in the cultures 
without citrate, but not in cultures with citrate. Moreover, the glucose utilization was improved 
in the presence of citrate. The remarkable difference was the enhancement in cell density in the 
presence of small amount of citrate. To assess whether the cell density enhancement is only due 
to higher levels of substrate utilization (higher glucose consumption and utilization of citrate), 
the values of cell yield based on total carbon consumed were calculated. The significantly higher 
values of cell yield exhibited in presence of citrate for dilution rates of 0.2 and 0.3 h-1 indicates 
that citrate has shifted the carbon metabolism more towards biosynthetic reactions. Finally, for a 
dilution rate of 0.4 h-1 (run 7 and 8), the culture without citrate was unstable in that the cell 
density continually decreased after the onset of the continuous medium flow. The maximum 
growth rate in batch cultures with the same medium is 0.49 h-1. Thus, the culture washout is not 
due to dilution rate being larger than the maximum growth rate in batch culture.  Rather, washout 
may be due to excessive acid formation or other metabolic factors repressing cell growth. Indeed, 
one sample taken 18 hours after the initiation of continuous culture showed OD660nm = 0.58 
and acetic acid concentration of 0.32 g/l.  
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Table 9. Biomass yields and acetate production in continuous cultures of Bacillus thuringiensis at different 
levels of dilution rates (3 g/L glucose) 
 
Exp 
No 
D 
(h-1) 
Citrate 
(g/L) 
Residue 
Glucose 
(g/L)  
Residue 
Citrate 
(g/L) 
OD 
(660nm) 
Biomass 
Yielda 
(%) 
Acetate 
(g/L) 
1 0.1 0 0 0 4.18 61 0 
2 0.1 0.5 0 0 5.58 81 0 
3 0.2 0 0.93 0 2.45 52 0.33 
4 0.2 0.5 0 0 5.28 77 0 
5 0.3 0 1.41 0 1.81 50 0.42 
6 0.3 0.5 0.63 0 3.53 65 0 
7 0.4 0 Washout      
8 0.4 0.5 1.68 0 1.95 65 0.05 
 
a) Biomass yield is defined as gram of carbon in the cell/gram of carbon consumed from glucose, 
assuming the carbon content in biomass is 50%. 
b)  1.0 g/L LB was fed in the medium. 
 
 
6.2.7 Glucose Utilization in Continuous Cultures of Bt. 
Table 10 shows the glucose utilization, biomass synthesis, and acetate production in 
continuous cultures of Bt at dilution rate of 0.2 h-1 with varying glucose concentration. The 
citrate concentration was set at 0.5 g/L, while 2, 3, and 5 g/L glucose concentration were 
investigated. Glucose was completely utilized and no remarkable acetate formation occurred for 
both single feeding and dual feeding cultures when 2 g/L glucose was initially supplied (run 1 
and 2 in Table 10). In this situation, the glucose consumption rate was limited by the low glucose 
feeding rate; therefore, the glycolysis flux was under well control and no overflow of glycolysis 
would happen.  
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The feeding glucose concentration was then increased from 2 g/L to 3 g/L (run 3 and 4 in 
Table 10), accompanied by a decrease in the ratio of Citrate/Glucose. All glucose was utilized in 
the culture with citrate, while there is still some amount of glucose left unconsumed in the single 
feeding. Considering the consumption of glucose, it is obvious that citrate is beneficial to the 
catabolism of glucose. The higher glucose catabolism in dual feeding culture was rather due to 
the higher cell concentration than higher specific glucose uptake rate, as the glucose uptake rate 
per cell is much lower in the dual feeding cultures. Accompanied with the higher specific 
glucose uptake rate, more acetate was produced for the single feeding, while the specific glucose 
uptake rate for the dual feeding is still low and no acetate is produced.  
Glucose utilization was incomplete for both single feeding and dual feeding cultures 
when 5 g/L glucose was initially supplied (run 5 and 6 in Table 10), with more than 50% feeding 
glucose left unconsumed after the system reached steady state. Compared with run 3 and 4, less 
glucose was consumed for the single feeding and dual feeding respectively. This was probably 
due to the lower citrate/glucose and LB/glucose ratio in run 5 and 6. As we keep the same ratios 
of citrate/glucose and LB/glucose in the culture with 5 g/L glucose as that in the cultures with 3 
g/L glucose, more glucose was consumed (run 7 and 8). When 1 g/L LB was fed into the 
continuous culture, about 2 g/L glucose would be consumed, which is very consistent with our 
previous batch results.  
The results of Table 9 and Table 10 indicated that, with citrate addition, acid formation 
was diminished and the cell yield increased remarkably.  Furthermore, the differences of cell 
density, biomass yield and acetate production between single feeding and dual feeding are most 
significant for the cultures with moderate feeding ratio of citrate/glucose (0.5/3) as shown in 
Table 10. It was reported that the effect of citrate is at regulatory level in B. subtilis by altering 
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the metabolic fluxes in the central carbon metabolic pathways, not due to the fact that citrate is a 
TCA cycle metabolite (Goel et al, 1995). Metabolic flux analysis was then carried out to check 
the changes of metabolic fluxes in the Bt culture after it was exposed to citrate.  
 
Table 10. Biomass yields and acetate production in continuous cultures of Bacillus thuringiensis 
supplemented with different amount of glucose at dilution rate of 0.2 h-1
 
Exp 
No 
Initial 
Glucose 
(g/L) 
Feeding 
Citrate 
(g/L) 
Residue 
Glucose 
(g/L)  
Residue 
Citrate 
(g/L) 
OD 
(660nm) 
Biomass 
Yield* 
(%) 
Acetate 
(g/L) 
Glucose 
uptake rate  
mmol/(g.hr) 
1 2 0 0 0 3.02 0.53 0.04 2.10 
2 2 0.5 0 0 3.44 0.60 0 1.85 
3 3 0 0.93 0 2.45 41 0.33 2.68 
4 3 0.5 0 0 5.28 62 0 1.80 
5 5 0 3.43+0.11 0 2.25+0.21 50+0.95 0.11+0.02 2.22 
6 5 0.5 2.67+0.10 0 4.35+0.08 65+1.5 0 1.70 
7** 5 0 2.33 0 3.98 52 0.15 2.13 
8** 5 0.85 2.02 0.06 5.01 59 0 1.89 
 
*Biomass yield is the carbon yield on glucose. 
** Run #7 and run # 8 were fed with 1.67 g/L LB; run #1 to #6 were fed with 1.0 g/L LB 
 
6.2.8 Network Model for Metabolic Flux Prediction and Calculation 
We have previously reported that the effect of citrate in B. subtilis is not due to 
augmenting the abundance of a TCA cycle metabolite. Instead, the effect is at the regulatory 
level resulting in the alteration of the fluxes in the central metabolic pathways (Goel et al, 1996, 
Lee et al., 1997; Phalakornkule et al., 2000). Metabolic fluxes (mmol/(g cell ·h)) for glucose and 
glucose plus citrate fed cultures of Bt (run 3 and 4 in Table 9) were calculated using a 
stoichiometric model as described elsewhere (Zhu et al., 2003).    
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Bt has an incomplete TCA cycle owing to the absence of the α-ketoglutarate 
dehydrogenase (Nickerson et al., 1974b; Yousten et al., 1974; Aronson et al., 1975). However, 
there is an ancillary pathway that allows for glutamate and α-ketoglutarate metabolism via the γ-
aminobutyric acid pathway (Aronson et al., 1975). Figure 6.6 depicts the metabolic pathways 
included in our flux model. A stoichiometric model of the central carbon metabolism of Bt was 
built using the software Metabologica (Zhu et al., 2003).  The model assumes that all metabolic 
intermediates are at the pseudo-steady-state (no accumulation of metabolic pools). Additionally, 
constraints such as net NADPH formation for reductive biosynthesis and minimum ATP 
requirements are included in the model formulation. These constraints limit the metabolite 
trafficking alternatives as well as insure that a particular solution is physiologically feasible. 
Biomass composition data was adopted from B. subtilis (Sauer et al., 1996). We have reported 
that slight variations in cell composition do not significantly affect the relative distribution of key 
fluxes between glycolysis and TCA cycle (Goel et al., 1995).  
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 Figure 6.6. Scheme of central carbon metabolism pathways for flux modeling in Bt. 
Abbreviations: aa (amino acids); na (nucleic acids); G6P (glucose-6-phosphate); F6P (fructose-6-phosphate); R5P 
(ribose-5-phosphate); E4P (erythrose-4-phosphate); FDP (Fructose-1,6-biphosphate); DHAP (dihydroxyacetone-
phosphate); GAP (Glyceraldehyde-3-phosphate); S7P (sedoheptulose-7-P); PGP (1,3-biphosphoglycerate); 3GP (3-
phosphoglycerate); PEP (phosphoenolpyruvate); AcCoA (acetyl-CoA); CitrateEx (Citrate External); KG (α-
ketoglutarate); GABA (4-aminobutanote); Succ (succinate); OAA(oxaloacetate). 
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First, the effect of LB on fluxes was neglected and the cultures were treated as they were 
grown on glucose or glucose plus citrate. Two feasible solutions were found for cultures grown 
on glucose (3 g/l glucose) and four for cultures grown on glucose and citrate (3 g/l glucose and 
0.5 g/l citrate). The actual solution is a linear combination of these solutions. The possible 
solutions of HMP pathway and pyruvate kinase (PYK) fluxes at dilution rate of 0.2 h-1 are shown 
in Figure 6.7. For the entire solution space, PYK pathway flux of glucose plus citrate-fed culture 
is lower than that when citrate is absent.  High HMP flux is always accompanied by low PYK 
flux, and vice versa. It has been reported that most strains of Bt and other bacteria use primarily 
the EMP pathway for glucose catabolism, and the use of HMP pathway is not significant 
(Nickerson et al, 1974c). Therefore, the solution for glucose fed culture (without citrate) is most 
likely to be around the maximum PYK flux as point A in Figure 6.7.    
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Figure 6.7. The solution space of HMP pathway flux and PYK flux for single feeding (3 g/L glucose) 
and dual feeding (3 g/L glucose and 0.5 g/L citrate) at dilution rate of 0.2 h-1. 
Note that two of solutions are the same (as far as HMP and PYK flux) for glucose with citrate case. 
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The average of main pathway fluxes for the glucose and glucose plus citrate-fed cultures 
for a dilution rate of 0.2 h-1 are given in Figure 6.8. Glycolytic fluxes were significantly lower for 
cells grown in the presence of citrate than its absence, while the fluxes through the TCA cycle 
were similar in the presence or absence of citrate indicating a possible saturation of TCA cycle. 
The most significant difference between the two cases was in flux of pyruvate kinase-catalyzed 
reaction; its value for the culture grown in the presence of citrate is about 33% of the value for 
the culture grown without citrate. It is reported that citrate transport is coupled with the uptake of 
divalent metal ions like Ca2+, which is a strong inhibitor of PYK (Willecke and Pardee, 1971; 
Boiteux et al., 1983). PYK inhibition can elevate PEP pool, which can further inhibit 
phosphofructokinase (PFK) (Fry, et al., 2000; Doelle et al., 1982) and lower glycolysis flux.  
As noted in evaluation of metabolic fluxes of Figures 6.7 and 6.8, the contribution of LB 
to metabolic fluxes was neglected. To account for some of the effects of LB, the flux model was 
modified such that amino acids were provided by the LB and thus no biosynthetic precursors 
were used for amino acid synthesis. The ATP and NADPH constraints of the flux model were 
also modified by taking into account that no ATP and reducing power (NADPH) was used for 
amino acid synthesis. Five feasible solutions were obtained for glucose plus citrate grown cells 
with PYK flux value of 0.833, 1.048, 1.086, 1.181, 1.181 mmol/ (g cell.h). Four were found for 
glucose-fed cultures: the PYK flux values equal 1.823, 2.029, 2.061, and 2.061 mmol/(g cell h). 
Similar to the first case where the effect of LB was completely neglected, PYK fluxes are 
significantly lower for the glucose plus citrate fed culture than the culture without citrate.   
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Figure 6.8. Metabolic fluxes of continuous culture of Bt at dilution rate of 0.2 h-1 for glucose fed (3 
g/L glucose) (first number) and glucose plus citrate (3 g/L glucose + 0.5 g/L citrate) (number in parenthesis). 
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Finally, using the Metabologica (Zhu et al., 2003), possible flux distribution scenarios for 
the growth of Bt in glucose minimal medium was investigated.   Sixteen different feasible 
solutions exist. The acids flux versus PYK flux (mmol/(g cell·hr)) is shown in the phase plane 
(Figure 6.9A). Any point inside the bounded region is a feasible solution. The maximum and 
minimum acids production rate decreases linearly as the PYK flux decreases. The geometry of 
the phase plane boundary also indicates that solutions that yield zero acids exist as the PYK flux 
decreases to a low range of values. Figures 6.9A and B show that higher biomass yield is 
correlated to lower acids and PYK flux. Thus, both the modeling and experimental results 
indicate that PYK may be a possible metabolic engineering site to reduce acetate production and 
improve biomass yield. 
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Figure 6.9. Phase plane for acids flux vs. PYK flux (A), acids flux vs. Glucose Uptake Rate (B). 
The fluxes were generated with the modeling software at dilution rate of 0.2 hr-1.   
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These results demonstrated that citrate was very effective in reducing acid formation and 
enhancing cell density in continuous cultures operated at moderate to relatively high growth 
rates. Citrate was not as effective in batch cultures particularly during the early exponential 
phase when the growth rate is high due to the presence of LB and low concentration of inhibitory 
by-products. Based on these results, it is likely that citrate will be effective in reducing acid 
production in fed-batch cultures where the growth rate is sustained below the maximum growth 
rate. 
We have reported that in B. subtilis, citrate attenuates the activities of pyruvate kinase 
and phosphofructose kinase, both of which are known to exert significant control over glycolysis 
(Goel et al., 1999). Since the observed redistribution of fluxes due to addition of citrate is similar 
in B. subtilis and Bt, the same mechanism may be operative in both microorganisms. This 
implication suggests that as was the case for B. subtilis, abolishing pyruvate kinase activity (Fry 
et al., 2000) or inducing expression at a low level (Pan et al., 2006) may prove beneficial for 
reducing acetic acid and enhancing product (e.g. crystal protein) production in Bt cultures.   
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7.0  CONCLUSIONS  
 The poor coordination between glucose consumption and precursor synthesis in the 
Krebs cycle often results in carbon overflow and excess acetate production. The acetate 
formation during microbial fermentation inhibits cell growth and recombinant protein 
production, and causes the instability of fermentation process. Here, we have demonstrated that 
the efficiency of carbon utilization can be markedly increased by regulating pyruvate kinase 
(PYK) expression in B. subtilis and by cofeeding citrate in B. thuringiensis. Outcomes of this 
study can be summarized as following. 
1. Good growth and low acetate formation in B. subtilis can be attained by controlling 
either PYK or Phosphofructokinase (PFK) at an intermediate expression level. 
2. Down-regulating pyk expression resulted in elevated concentrations of intracellular 
PEP and G6P therefore enhanced folic acid production.  
3. Recombinant protein production is improved by down-regulating pyk expression. 
4. Glycerol is a better carbon source for recombinant protein production as compare to 
glucose. In addition to higher protein productivity, cultures with glycerol also result in 
less acetate formation and higher biomass yield. 
5. Feeding of citrate in the continuous cultures of Bacillus thuringiensis is very effective 
in reducing acetate formation, which results in improved cellular yield. 
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8.0  FUTURE WORK  
 Although the strain of B. subtilis with regulated PYK activity shows promise, the need 
for an external inducer supplied in the media is cumbersome and can increase the difficulty and 
cost of downstream processing. Based on the results presented in this study, a strain with a 
weaker promoter whose PYK expression level is equal or close to the induction level of iPYK 
mutant with 0.05 mM IPTG may have potential applications. 
 Down-regulating pyk expression reduced acetate formation but increased carbon dioxide 
evolution in B. subtilis. Modeling results indicate a solution maximizing carbon yield also 
corresponds to low PYK and α-Ketoglutarate dehydrogenase (α-KDH) activities. A double 
mutation of PYK and α-KDH may give low rates of acetate formation and CO2 evolution thereby 
further increases biomass yield.  
 Citrate is very effective in reducing acetate formation and improving cellular yield in 
continuous cultures of B. thuringiensis. However, the effectiveness of citrate in batch cultures is 
limited due to the catabolic repression of citrate transport by glucose. In B. subtilis, citrate is 
proposed to attenuate PYK. Same mechanism may be operative in both microorganisms. As was 
the case for B. subtilis, abolishing pyruvate kinase activity (Fry et al., 2000) or inducing 
expression at a low level (Pan et al., 2006) may prove beneficial for reducing acetate and 
enhancing product (e.g. crystal protein) production in B. thuringiensis cultures. 
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APPENDIX A 
PREPARE COMPETENT B. SUBTILIS AND TRANSFORMATION 
1. Grow one loop of B. subtilis in LB overnight. 
2. 1 ml overnight culture was then inoculated into 20mL growth medium GM1, and optical 
density was measured for every hour. 
3. Record the time of cessation of logarithmic growth T0. 
4. Continue culture in GM1 for 90 minutes (T90). 
5. Dilute the culture 10-fold into GM2, and incubated at 37 °C and 250 rpm for 60 minutes. 
6. Add DNA (1 to 5 µg/mL), and continue incubation for 30 minutes. 
7. Terminate the reaction by adding 100 µg/mL of deoxyribonuclease (DNase) and incubate 
at 37 °C for 5 minutes. 
8. Spread 0.1 mL onto LB agar plate with appropriate antibiotics and incubate for 24 hours. 
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Reagents: 
10× Salts (/L):  
 140 g  K2HPO4 
  60 g  KH2PO4 
 20 g  (NH4)2SO4 
 10 g  sodium citrate 
 2.0 g  MgSO4·7H2O 
 
1× GM1: 
 22mM glucose 
 0.02% acid hydrolyzed casein 
 0.1% yeast extract 
 10% 10× Salts 
 
1× GM2: 
 1× GM1 
 0.5 mM CaCl2
 2.5 mM MgCl2
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APPENDIX B 
ISOLATION OF PLASMID DNA FROM BACILLUS SUBTILIS USING THE QIAGEN® 
PLASMID MIDI KIT 
This procedure has been adapted from the QIAGEN® Plasmid Midi Kit Protocol. It has been 
used successfully for isolation of low-copy-number plasmids from various Bacillus subtilis 
strains. 
 
Procedure 
1. Take 2~5 ml sample during the mid-exponential stage culture.  
2. Harvest the cells by centrifugation at 10000 x g for 5 min at 4°C. 
3. Resuspend the bacterial pellet in 4 ml Buffer P1 containing 5 mg/ml lysozyme. Ensure that 
RNase A (100 µg/ml) has been added to Buffer P1. 
4. Incubate at 37°C for 30 min. 
5. Add 4 ml Buffer P2, and mix gently but thoroughly by inverting 4~6 times, and incubate at 
room temperature for 5 min. (Check Buffer P2 before use for SDS precipitation due to low 
storage temperatures. If necessary, dissolve the SDS by warming to 37°C). 
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6. Add 4 ml chilled Buffer P3, mix immediately but gently by inverting 4~6 times, and incubate 
on ice for 15 min. 
7. Centrifuge at 14,000 × g for 10 min at 4°C. Remove supernatant containing plasmid DNA 
promptly. 
8. Apply the supernatant from step 7 to the QIAGEN-tip and centrifuge for 1 minute. 
9. Wash the QIAGEN-tip with 2 × 10 ml Buffer QC. 
13. Elute DNA with 5 ml Buffer QF. 
14. Precipitate DNA by adding 3.5 ml room-temperature isopropanol to the eluted DNA. 
Mix and centrifuge immediately at ≥15,000 x g for 30 min at 4°C. Carefully decant the 
supernatant. 
15. Wash the DNA pellet with 2 ml of room-temperature 70% ethanol and centrifuge at 
≥15,000 x g for 10 min. Carefully decant the supernatant without disturbing the pellet. 
16. Air-dry the pellet for 5.10 min, and redissolve the DNA in a suitable volume of buffer 
(e.g., TE, pH 8.0, or 10 mM Tris·Cl, pH 8.5). 
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APPENDIX C 
AGAROSE GEL ELECTROPHORESIS 
Procedure: 
1. Weight 0.7 to 1.0 g agarose and dissolve in 1× running buffer (TBE) by heating in 
microwave for 1 to 2 minutes. 
2. Cool down the hot agarose solution to 60~70 °C, pour the warm agarose solution into 
mould with comb inserted, cool for 30 to 60 minutes. 
3. Remove comb. With gel in electrophoresis chamber, add 1× TBE buffer till the gel is 
submerged completely.  
4. Mix 9 parts DNA sample with 1 part dye with a total volume of 10~20 µl, and load the 
samples and DNA marker into wells of gel. 
5. Place lid on top of chamber. 
6. Set and turn on the power supply at 90 voltage, and let it run for 1~3 hour. 
7. Turn off power supply. 
8. Carefully remove gel from mold and stained in bath of 1 µg/ml ethidium bromide for 
about 30 minutes. 
9. Remove gel from the staining container, and rinse in bath of water for 30 minutes. 
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10. Examine gel on UV light talbe. 
 
Reagents: 
20×TBE Buffer (stock solution) 
 216 g  Tris base 
 110 g  Boric acid 
 80 mL  0.5M EDTA, pH 8.0 
Adjust to final volume of 1 L with distilled water. 
Dilute to 1× for use in electrophorisis. 
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